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Hydrogels are gaining interest as biomaterials in bone tissue engineering (BTE). However, 
hydrogels must be mechanically stable, receptive to mineralisation, non-cytotoxic and 
support adhesion and growth of bone forming cells. Ease of sterilisation and antibacterial 
activity are also desirable.  
This study evaluated the extent to which three hydrogels fulfilled these criteria: 
1. Electron irradiated Gelatin hydrogels supplemented with Alkaline Phosphatase (ALP) 
2. Whey Protein Isolate (WPI) hydrogels supplemented with Phloroglucinol (PG) 
3. WPI hydrogels supplemented with Carbon Nanotubes (CNTs) 
Methods 
Gelatin hydrogels were crosslinked using electron beam irradiation and subject to ALP-
mediated mineralisation. Mineralisation was evaluated by spectroscopic and microscopical 
techniques. Mechanical properties were examined via compressive testing. 
Cytocompatibility was assessed using osteoblast-like MG-63 cells. 
Similarly, 40% WPI solution was supplemented with CNTs or PG prior to simultaneous 
hydrogel fabrication and sterilisation by autoclaving. Antibacterial properties of WPI-CNT 
hydrogels were assessed using Staphylococcus aureus. Cell viability was assessed against 
Human Foetal Osteoblast (hFOB; WPI-CNT only) and MG-63 cells. Surface topography and 
molecular structures were evaluated microscopically and spectroscopically. The effect of 






Calcium phosphate (CaP) deposits were successfully formed in gelatin-ALP hydrogels, which 
coincided with an elevated compressive modulus. Importantly, electron beam-crosslinked 
hydrogels, both mineralized and unmineralized, supported MG-63 cell adhesion and 
proliferation.  
Both CNTs and PG were successfully incorporated into WPI hydrogels. CNTs interacted with 
WPI and increased stiffness, but not compressive strength, of hydrogel composites. PG 
concentration had little impact on hydrogel mechanical properties. Importantly, WPI-CNT 
hydrogels exhibited antibacterial activity and supported growth of MG-63 cells. However, 
MG-63 viability appeared to reduce with increasing PG concentration. 
Conclusions 
The successful supplementation of hydrogels with additives to confer desirable properties, 
coupled with the practicality of simultaneous fabrication and sterilisation, demonstrates 












Chapter 1: Introduction 
1.0 Introduction 
In the past, surgery conducted on the human body primarily took place in the absence of 
additives, such as implants, which are now available to facilitate surgical interventions. Since 
then, advancements in the understanding of human anatomy, coupled with the 
identification of materials compatible with the body, has driven an increase in the demand 
for medical implants (Axinte et al.,2019; Saptaji et al., 2018). These materials, termed 
Biomaterials, are either natural or engineered substances that can interact with biological 
systems to therapeutic effect. Implanted materials may be utilised as short term, long term, 
or permanent aids to treat, repair, or replace biological tissue in numerous applications 
including drug delivery systems, the cardiovascular system, and orthopaedics, which is the 
focus of the present study (Bartolo et al., 2012; Khan et al., 2014; Mitsuishi et al., 2013). 
1.1 Bone Tissue - A Natural Composite 
As the average life-expectancy and chronological age of the worldwide population increases, 
the incidence of bone related disorders and conditions has elevated considerably. This is of 
particular significance in populations where obesity and insufficient physical activity 
coincides with aging. Even though bone is a dynamic vascularised tissue with the capability 
to heal naturally in response to damage, hundreds of millions of surgical procedures are 
performed globally, each year, to correct severe bone lesions (Maisani et al., 2017). Recently, 
research into bone tissue engineering (BTE) has led to improvements in both surgical 
techniques and orthopaedic implants. However, skeletal conditions remain undertreated.  
Bone, along with muscles, ligaments, tendons, the nervous system and other soft tissue 
forms the musculoskeletal system. These components work synergistically to perform the 
primary functions of this system – mechanical support, facilitation of regular movement, and 




weight, is comprised of approximately 30% matrix, 60% mineral and 10% water (Athanasiou 
et al., 2000). Typically, this cellularised composite is split into two main components: 
inner spongy bone and outer dense bone. These are known as cancellous or trabecular 
bone and cortical bone, respectively. In the skeletal system, the relative mass ratio of 
these two types of bone is 20% to 80% in favour of cortical bone.  
1.1.1 Cortical Bone 
The basic structural units which comprise cortical, or compact, bone are cylindrical structures 
with approximate diameters and lengths of 200µm and 400µm, respectively. These 
structures are known as osteons, or haversian systems, and possess channels within them 
(haversian canals) which contain blood vessels encompassed by concentric lamellae of 
mineralised matrix. Lacunae, small cavities within the mineralised matrix, each with an 
osteocyte present, are connected to the haversian canals by a network of small channels 
known as canaliculi. This facilitates cell-to-cell interactions and allows the exchange of 
nutrients and metabolites (Maisani et al, 2017). 
1.1.2 Cancellous Bone 
Like cortical bone, cancellous bone is composed of lamellae. However, in contrast, the 
lamellae of cancellous bone are organised into a honeycomb-like network, loosely structured 
and void of internal canals and blood vessels. In fact, only 15 to 20% of trabecular bone 
volume is occupied by bone tissue. Most of the trabecular network is occupied by bone 
marrow which, itself, consists of blood vessels, nerves, and several other cell types that 
provide nutrients to trabecular osteocytes (Maisani et al, 2017).  
1.1.3 Bone Extracellular Matrix (ECM) 
The bone extracellular matrix (ECM) is broadly characterised by an organic protein phase and 
an inorganic mineral containing phase. Despite the presence of calcium carbonate, calcium 




primarily of embedded hydroxyapatite (HA; Ca10(PO4)6(OH)2) crystals, which confers stiffness 
and compressive strength to bone. Additionally, the inorganic component of bone is 
implicated strongly in the homeostasis of ions, as up to 99% of calcium and 88% of 
phosphate in the human body is encompassed within it (Driessens et al., 1978; Sasaki et al., 
1989). 
The organic phase is comprised primarily (approximately 90%) of type I collagen organised into 
a network of triple helices, which subsequently form fibrils. The remaining 10% consists of 
supplementary proteins, such as proteoglycans (PGs), growth factors, and glycoproteins. 
Whereas the mineral component imparts compressive strength, the organic ECM provides 
numerous structural roles. It regulates the shape of bone by controlling the nucleation and 
direction of HA crystals, is responsible for fracture resistance and tensile strength (Maisani et 
al., 2017; Sheikh et al., 2015), and, importantly, acts as a reservoir for cytokines and growth 
factors which are necessary for the repair and remodelling of bone tissue. 
 In addition to these primary components, the previously mentioned non-collagenous 
proteins confer important functions to bone tissue. For example, PGs impart the ability to 
resist compressive stress as they form a highly hydrated, swollen gel-like matrix. They also 
fulfil roles in the binding and storage of growth factors and in the regulation of 
fibrillogenesis (Lamoureux et al., 2007). Glycoproteins of the bone ECM, such as alkaline 
phosphatase (ALP), osteocalcin and osteopontin, provide similarly important roles, as they 
are involved directly in the process of bone mineralisation (Maisani et al., 2017). 
1.2 Natural Bone Healing 
As previously stated, bone is a dynamic tissue. As such, it continually adapts during 
vertebrate life to first achieve, and subsequently maintain, skeletal size, shape, structural 
integrity, and to regulate mineral homeostasis (Raggatt and Partridge, 2010). This continual 




1.2.1 Bone Modelling 
Bone modelling occurs primarily during childhood and adolescence, as it is the process 
responsible for bone growth and the coordination of mechanically induced transformations 
in bone shape. For this to happen, it is necessary for the processes of bone formation and 
bone resorption to occur independently, at discrete locations (Maisani et al., 2017; Raggatt 
and Partridge, 2010). 
1.2.2 Bone Remodelling 
Bone remodelling is a continuous process which occurs in response to damaged bone. This 
includes the removal, repair and renewal of bone tissue to maintain the strength and 
integrity of the skeletal system, whilst ensuring mineral homeostasis (Raggatt and Partridge, 
2010). This process is tightly regulated by the synergistic action of an ensemble of cell types 
including bone forming osteoblasts and bone resorbing osteoclasts, arranged within 
temporary bone remodelling structures named basic multicellular units or bone metabolic 
units (BMUs; Maisani et al., 2017; Raggatt and Partridge, 2010). 
1.2.2.1 Activation Phase 
Bone remodelling can be initiated in response to numerous signals. Stimulatory signals can 
originate from structural damage resulting from direct mechanical strain, or via hormonal 
stimuli in response to systemic fluctuations in homeostasis (Raggatt and Partridge, 2010).  
Mechanical stimuli are detected by osteocytes which, ultimately, translate it into biological 
signals that result in bone remodelling initiation (Bonewald, 2007). Specifically, damage, such 
as damage to the bone matrix or limb immobilisation, results in osteocyte apoptosis and 
increased osteoclastogenesis (Aguirre et al., 2006; Verborgt et al., 2002).  
Osteoclastogenesis, under basal conditions, is inhibited by the secretion of transforming 
growth factor β (TGF- β) by osteocytes. Following focal apoptosis of osteocytes, local TGF- β 
levels fall below the minimum inhibitory concentration. Therefore, osteoclastogenesis 




remodelling can involve hormones such as oestrogen or the parathyroid hormone (PTH), 
which maintains calcium homeostasis. Similarly, inactive osteoblasts located in bone lacunae 
function as sensors of mechanical strain. In response to this stress, they release paracrine 
signals which stimulate active osteoblasts and osteoclasts and direct the turnover of bone 
tissue (Maisani et al., 2017). 
1.2.2.2 Resorption Phase 
Following the initiation of the activation phase, osteoblasts respond to the bone remodelling 
signals produced as a result of the aforementioned processes. This response includes the 
production of cytokines necessary for osteoclastogenesis, the recruitment of osteoclast 
precursors, and the stimulation of these precursors to differentiate into multinucleated 
osteoclasts that ultimately initiate the bone resorption phase. Following stimulation by these 
cytokines, fusion of the mononuclear precursors of the haematopoietic lineage, from which 
osteoclasts are derived, produce large multinucleated cells (Teitelbaum and Ross, 2003). 
Osteoblasts also secrete matrix metalloproteinases (MMPs) in response to the remodelling 
signals (Partridge et al., 1987; Yang et al., 2004). MMP activity is necessary to allow the 
attachment of osteoclasts to mineralised bone. First, MMPs expose the RGD adhesion sites 
present in mineralised bone by degrading the unmineralized osteoid that lines its surface. 
Once exposed, osteoclasts can bind to these RGD sites, generating an isolated 
microenvironment below the cell (the sealed zone). Once established, hydrogen ions are 
pumped through membrane proton pumps into the sealed zone to create an acidic 
environment (ca. pH 4.5). This results in the dissolution of the mineral component of the 
matrix and the production of the resorptive pit (Howship’s lacunae; Teitelbaum, 2000). 
Subsequently, cathepsin K, along with other collagenolytic enzymes, degrades the organic 
ECM. The Howship lacunae, however, remains covered with demineralised collagen matrix 




lineage (reversal cells), that are substituted for osteoclast cells as they undergo apoptosis. 
Reversal cells then prepare the bone surface for new bone tissue deposition (Delaisse, 2014). 
1.2.2.3 Reversal and Formation Phases 
Following this process, the resorptive pit houses osteocytes released from the resorbed bone 
matrix, pre-osteoblasts enlisted from the medullary cavity, mesenchymal stromal cells 
(MSCs) and a fibrous membrane which covers the exterior of bone. This membrane is 
populated by mature osteoclasts, reversal cells, progenitor cells and signals released from 
the previously degraded matrix (Maisani et al., 2017). Numerous growth factors, including 
TGF-β, fibroblast growth factor (FGF) and bone morphogenetic proteins (BMPs) stimulate the 
differentiation of progenitor cells into mature osteoblasts, which, in turn, synthesise new 
bone ECM. Subsequently, these mature osteoblasts pursue one of three possible fates: 
undergo apoptosis, remain embedded in the newly formed mineralised tissue and transition 
to the osteocyte phenotype, or, finally, become a quiescent osteoblast with a flat 
morphology, known as a bone lining cell, and inhabit non-remodelling bone surfaces (Miller 
et al., 1989). 
1.2.2.4 Termination Phase 
The process of bone remodelling is terminated when the remodelling machinery is 
stimulated to conclude its work as a result of largely unknown signals that communicate that 
an equal quantity of resorbed bone has been replaced. Finally, the resting bone surface 
environment is achieved and maintained until bone remodelling is initiated again upon 
















1.2.3 Bone Healing 
Bone tissue also possesses the intrinsic ability to respond to damage and repair itself. 
Following damage, such as a fracture, there is a resultant disruption in the bone vascular 
network which minimises nutrient and oxygen exchange and affects the structure of bone 
marrow. Ultimately, this leads to local loss of skeletal integrity (Baldini et al., 2009). 
Immediately following trauma of this nature, the first of three main phases of fracture 
healing begins (Inflammatory/reactive phase, reparative/regenerative phase, and the 
remodelling phase; Oryan et al., 2012).  
1.2.3.1 Inflammatory Phase 
As the name suggests, the inflammatory phase begins with local inflammation and the 
formation of a haematoma within 12 to 14 hours after damage occurs. This haematoma 
supplies a matrix which facilitates the migration of cells involved in the acute inflammatory 
response: inflammatory cells, endothelial cells and fibroblasts. Neutrophils are the first 












Figure 1: A representation of the physiological process of bone remodelling. Adapted 




and plasma cells. Macrophages remove necrotic tissue and debris by phagocytosis and, along 
with platelets and bone cells, release cytokines and growth factors responsible for the 
initiation of the healing process (Doblare et al., 2004; LaStayo et al., 2003; Moshiri and 
Oryan, 2012). Amongst these are TGF-β, platelet derived growth factor (PDGF), vascular 
endothelial growth factors (VEGFs), fibroblast growth factors (FGFs), Interlukin-1 and 6 (IL-1 
and IL-6), BMPs, tumour necrosis factor α (TNF-α), and macrophage colony stimulating factor 
(Moshiri and Oryan, 2013; Parizi et al., 2011; Webb and Tricker, 2000). The release of these 
factors initiates the migration of multipotent mesenchymal stem cells (primarily originating 
from bone marrow and the periosteum) and stimulate their differentiation into fibroblasts, 
angioblasts, chondroblasts and osteoblasts, that are necessary for the angiogenesis and 
synthesis of the ECM (Moshiri and Oryan, 2013; Oryan and Moshiri, 2012). Ultimately, this 
results in the formation of transient granulation tissue with low stiffness and tensile strength 
(Schindler et al., 2008). 
1.2.3.2 Reparative Phase 
The reparative phase consists primarily of the formation of the fracture-callus. The fibrin-rich 
granulation tissue produced prior to this stage is used as a natural scaffold to produce a soft 
callus which stabilises the fracture site. This occurs via one of two methods of ossification: 
endochondral or intramembranous ossification. Endochondral ossification relies on the 
deposition of a cartilaginous callus across the fracture site, which is subsequently 
vascularised and calcified. However, at this stage, the callus remains mechanically weak, as it 
is characterised by a random organisation of collagen fibres (Maisani et al., 2017).  
Intramembranous ossification is characterised by high partial pressure of oxygen and a 
functional capillary network (Marzona and Pavolini, 2009). In this case, cartilage deposition is 




Progressively, osteoblasts replace the calcified cartilage with woven bone. Once this occurs, 
the mechanical properties increase with the formation of a hard callus. Calcified cartilage 
stimulates the recruitment of osteoclasts which allow the woven bone to replace the 
cartilage matrix, and osteoblasts into the fracture site, in addition to inducing angiogenesis 
(Marsell and Einhorn, 2011).  
1.2.3.3 Remodelling Phase 
In the final phase, the woven bone is remodelled into new cortical or trabecular bone tissue 
with a lamellar structure. The duration of this phase can often be months or years, until the 
original biomechanical properties and integrity of the fractured bone is restored. This is 
achieved, briefly, by the deposition of bone by osteoblasts to replace the callus which is 
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1.3 Bone Defects 
Intrinsic bone healing is often insufficient. This issue occurs in relation to segmental bone 
defects (SBDs) – bone injuries resulting in a section of bone tissue being completely 
shattered or absent. If the loss of bone tissue is large enough, or, specifically, more than two 
and a half times the radius of the bone, this defect is termed a critical sized defect. In these 
cases, bone is incapable of regenerating without medical intervention (Pilia et al., 2013; 
Schroeder and Mosheiff, 2011). Similarly, medical intervention and corrective surgery is 
necessary when a defect results in a non-union (pseudoarthrosis) or malunion and, 
ultimately, a loss of function. A malunion occurs when the natural healing process can form a 
bridge to attempt to reconnect the damaged ends of bone tissue, but this results in 
misalignment and resultant mechanical vulnerability. Whereas a non-union is the term used 
for the case in which the two ends of bone tissue cannot be reconnected, and a critical 
defect is formed (Pilia et al., 2013). 
SBDs, broadly, are brought about by one of three causes, the first of which is trauma. 
Trauma related causes can be further divided into fractures, sport injuries, and blast injuries. 
Blast injuries, as expected, are most prevalent amongst military personnel because of 
explosive detonations. These are the most severe cause of trauma related SBDs since other 
tissue, such as muscle and nervous tissue, is also affected. Fractures and sports injuries are 
less severe; however, they are characterised by the necessitated need for the surgical 
removal of shattered/fragmented pieces of bone (Pilia et al., 2013). 
The second significant cause is disease. Specifically, disease resulting in the abnormal 
weakening of bone tissue or the need for surgical removal to prevent disease transmission. 
This includes osteosarcoma, osteoporosis, osteoarthritis (Baino et al., 2009) congenital 
deformity corrections, generic infections, pathological degenerative bone destruction and 




third significant cause - aging. Increasing chronological age is accompanied by increased risk, 
and increased severity, of the prior significant causes of SBDs occurring.  
If SBDs remain untreated, complications, in the form of malunion, can mean the new bone 
will remain susceptible to fractures. This is frequently observed in undiagnosed fractures and 
can lead to a reduction in bone function (Pilia et al., 2013). Similarly, non-union can occur if 
the ends of the bone are not secured in place sufficiently, therefore allowing excessive 
movement and preventing the ossification of the callus. In both cases, surgical intervention is 
required to minimise further decline in functionality (Pilia et al., 2013). 
Therefore, coinciding with the aging population, orthopaedic trauma and resultant 
orthopaedic surgery is becoming more frequent. This trend of increasing orthopaedic needs 
is expected to continue in the coming years, therefore, increasing the need for cost efficient 
and effective treatments (Pilia et al., 2013). 
1.4 Current Treatment Methods 
Currently, except for blood, bone is the most frequently transplanted tissue (Eddy et al., 
2013). Conventional therapeutic approaches to the treatment of bone tissue defects include 
autografts, allografts, xenografts, and the implantation of exogenous materials, such as 
metal or ceramics.  
1.4.1 Autografts 
Bone transplant procedures ordinarily involve the transplantation of small fragments, to 
induce osteogenesis, or large fragments, to compensate for the loss of larger sections of 
bone tissue. 
Autologous bone grafts remain the ‘gold standard’ to augment bone tissue healing. Grafts of 
this nature mean that the recipient is also the donor. Autologous cancellous and 




patient, most frequently from the iliac bone, or the fibula. These are subsequently implanted 
back to the patient at the defect site (Gomez-Barrena et al., 2015; Schroeder and Mosheiff, 
2011). In addition to the absence of an elicited immune response, as the tissue is autologous, 
autografts possess the necessary characteristics to stimulate the growth of new bone tissue. 
They provide an osteoconductive scaffold, possess osteoprogenitor cells (and therefore 
osteogenicity), and the ability to induce the osteogenic differentiation of local stem cells 
(Goldberg, 2000; Shen et al., 2005; Urist, 1980). However, due to the autologous nature, the 
supply of appropriate bone is limited. Similarly, there are multiple other concerns including 
donor site morbidity, surgical limitations and elevated bone resorption during healing 
(Banwart et al., 1995; Sheikh et al, 2015). 
1.4.2 Allografts and Xenografts 
Allografts, the transfer of bone tissue sourced from a genetically different human donor, and 
xenografts, the transfer of bone tissue sourced from a different species, are alternative 
approaches. These methods negate the concerns regarding donor site morbidity and allow 
greater quantities of bone tissue to be transplanted. However, due to the necessary 
sterilisation and purification processes that must precede transplantation, the 
osteoinductive properties that accompany autografts are lost (Schroeder and Mosheiff, 
2011). Additionally, both methods (particularly xenografts), elicit a significant immune 
response in the host tissue, ultimately leading to rejection unless immunosuppressive 
medication is received. Similarly, grafts of this nature are accompanied by the risk of 
bacterial, viral, and prion transmission (Mankin et al., 2005). Finally, allografts/xenografts 
rarely integrate fully with host tissue. Most transplants result in only the periphery of the 
graft substituting successfully, leading to a subsequent graft fracture in as many as 60% of 




1.4.3 Metals and Metal Alloys 
The use of large prostheses, such as metals and metal alloys, is an additional method to 
remedy bone tissue defects. Metallic materials such as stainless steel, cobalt and chromium-
based alloys (Co-Cr), titanium (Ti) and titanium alloys have been widely used to produce 
bone plates, complete hip joints, dental components, pins, screws, and numerous load-
bearing implants for decades (Mediaswanti et al., 2013; Poinern et al., 2013). The reason for 
this is because their fracture resilience and high compressive and tensile strength mean they 
are equipped for high load-bearing applications (Poinern et al., 2013). However, prostheses 
of this kind are usually a temporary solution, with 30% of recipients requiring a revision 7 
years after the original procedure (Mittermayer et al., 2001). This is because metal/metal 
alloy implants lack a biological interface. As they do not interact, either chemically or 
biologically, with the surrounding tissue, there is minimal osteointegration or interfacial 
bonding. Therefore, over time, chronic wear or loosening renders the implant ineffective 
(Schroeder and Mosheiff, 2011). One of the primary disadvantages associated with metallic 
implants is ‘stress shielding’. This occurs due to the mismatch in mechanical properties 
between metallic implants and natural bone tissue which means, instead of transferring 
mechanical forces/loads onto the healing bone, it is retained by the implant. Ultimately, this 
results in unwanted bone resorption and implant loosening (Alexander and Theodos, 1993). 
Further disadvantages include: the risk of the implant damaging host tissue due to its weight 
and robustness, the release of toxic ions and particles via corrosion, allergic reactions and 
inflammatory cascades (Mediaswanti et al., 2013; Poinern et al., 2013). Even though metallic 
implants, particularly Ti alloys, with a higher resistance to corrosion and a reduced elastic 






Polymers are an additional category of biomaterials utilised as exogenous implants for bone 
tissue repair. They consist of many repeated units of small chemical monomers forming long 
chain molecules. These can be natural or synthetic, both of which have implications in 
numerous applications due to their properties: flexibility, low density, resilience and surface 
modifiability (Cooke et al., 1996). In terms of bone repair, polymers have been utilised as 
tissue scaffolds, bases for dentures, hip joint and cartilage replacements and as bone pins, 
screws and plates (Silver, 1994). Natural biodegradable polymers can be protein based, such 
as fibrin gel or collagen, or polysaccharide based, such as chitosan or hyaluronic based 
polymers (Poinern et al., 2013). Both of which have been used extensively in tissue 
engineering, particularly as scaffolds that allow cell attachment. Synthetic biodegradable 
polymers, including poly lactic acid (PLA), poly (L-lactic acid) (PLLA), poly-caprolactone (PCL) 
and poly glycolic acid (PGA), can be manufactured under controlled conditions to yield 
scaffolds with desired mechanical and physical properties. Furthermore, the degradation 
rate of synthetic polymers can be more easily controlled, while toxicity is also reduced 
(Poinern et al., 2013). Most commonly, PGA and PLA polymers are used clinically and can be 
manufactured with the most appropriate structure (disks, pellets, films or fibres) to satisfy 
specific applications (Poinern et al., 2013). Despite this, the mechanical strength of polymer 
implants is significantly lower than that of metallic implants. Their use in high load bearing 
applications is therefore limited, instead, their primary use is in soft tissue engineering 
(Poinern et al., 2013). Additional disadvantages associated with polymeric implants include 
disrupted or uneven integration of the surrounding tissue due to the irregular degradation of 
the scaffold and induction of the inflammatory response. Natural polymers also come 
associated with further risks surrounding the potential for disease transmission, like those 





Biological ceramics also have implications in bone tissue regeneration. These are inorganic, 
non-metallic materials that display chemical and thermal stability, durability, good wear 
resistance and physical strength (Hench and Wilson, 1993). They can also be sterilised with 
ease, are biocompatible, nontoxic, non-immunogenic and are readily available, which 
confers significant advantages in tissue regeneration. Furthermore, they can be shaped to fit 
a specific defect site or application (Hench, 1991).  
There are different categories of ceramics, each with slightly different applications. Bioinert 
ceramics, such as alumina, don’t interact with the surrounding tissue and are most used in 
dental implants (Best et al., 2008). Bioactive ceramics, such as bioactive glasses and 
hydroxyapatite (HA), directly interact with the adjacent tissue to elicit osteointegration 
(Gbureck, 2003). This property prompted the use of bioactive ceramics to coat metallic 
implants, such as Ti alloys, to increase post-implantation osteointegration (Shi and Jiang, 
1998). The third type, resorbable ceramics such as tricalcium phosphate (TCP), directly form 
a scaffold which promotes the proliferation of bone cells. This scaffold is slowly resorbed and 
replaced with the proliferating bone tissue (Campbell, 2003; Tancret et al., 2006). Finally, 
porous ceramics, such as HA coated metal implants, allow the infiltration of the surrounding 
tissue at the porous sites (Poinern et al, 2013). Again, however, there are multiple 
disadvantages associated with bioceramics. Primarily, these are associated with their low 
fracture toughness, tendency to be brittle and their lack of resilience (Poinern et al, 2013).  
Despite the varying advantages which accompany each of these conventional techniques, 
their overall effectiveness remains inadequate. In the USA alone, projections for the demand 
of hip and knee implants were estimated to increase by 174% and 673%, respectively, 
between 2005 and 2030 (Kurtz et al., 2007). Similarly, in Australia, primary and revision hip 




year (Mediaswanti et al, 2013). Therefore, highlighting the need for more effective, long 
lived, biomechanically and biocompatible materials for use in orthopaedic applications.  








Consequently, novel treatment options which address the existing issues with current 
orthopaedic treatments and offer all key elements of fracture healing and bone tissue 
regeneration are necessary. The ideal, or ‘holy grail’, treatment would be biocompatible (not 
elicit an adverse immune response upon implantation into the host), osteoinductive 
(promote stem cell differentiation), osteoconductive (promote the attachment, migration 
and proliferation of cells), capable of osteogenecity (production of new bone) when 
osteoprogenitor cells are present and promote vasculogenesis (Pilia et al., 2013 and Lu et al., 
2012). Additionally, this treatment, or synthetic material, would break down at the same rate 
that bone tissue is formed and would mimic the structural architecture and mechanical 
properties of natural bone tissue (Pilia et al., 2013). 
Tissue engineering strategies are currently being utilised to create such a treatment. 
Generally, this is a multifactorial approach combining metabolically active cells with a 
structurally supportive three-dimensional (3D) scaffold and molecular signals, such as growth 
Figure 3: Diagrammatic representation of the preparation and application of a scaffold 




factors, to achieve tissue growth (Drosse et al., 2008; Gomez-Barrena et al., 2015). Following 
the production of a 3D scaffold matching the geometry of the defect site, the appropriate 
cells and growth factors are loaded into it. Then, the scaffold is maintained in cell culture 
conditions to facilitate the proliferation of the loaded cells. Subsequently, the product of this 
procedure is implanted into the patient at the defect site to stimulate the regeneration of 
bone tissue (Drosse et al., 2008).  
The most compatible material to produce scaffolds of this nature, of course, is autologous 
bone. However, the previously discussed issues related to allografts necessitate the need for 
an alternative material. Preferably available in unrestricted quantities (Schieker et al., 2006). 
Numerous synthetic osteoconductive bone substitutes fitting the necessary criteria are 
available. These include bioactive glasses, calcium phosphate-based materials such as 
calcium hydroxyapatite and TCP, and other proteinaceous and carbohydrate-based 
substrates (Paderni et al., 2009).  
Similarly, multiple cell types have been investigated for their ability to enhance the efficiency 
of bone tissue engineering treatments.  Bone marrow stromal cells, periosteal cells and 
osteoblasts have all been investigated, however, adult mesenchymal stem cells (MSCs) 
appear to be the most appropriate (Groger et al., 2003 and Stangenberg et al., 2005). MSCs 
appear to have the largest implications for multiple reasons: ease of isolation, ease of 
expansion (in-vitro), and the ability to manipulate their progression from immature 
progenitor cells to specific cell types belonging to osteogenic, chondrogenic or adipogenic 
lineages (Drosse et al., 2008; Pittenger, 1999). 
Finally, many of the growth factors present in the matrix and osteoid of the skeletal system, 
involved in the natural processes of bone tissue regeneration, metabolism and overall 
function have been investigated to establish potential implications in the treatment of bone 




factor (bFGF) and BMPs. For example, the proliferation of bone marrow stromal cells was 
stimulated by fibroblast growth factor Two (FGF-2) in-vitro. When these stromal cells were 
seeded onto a bio-ceramic scaffold, cell differentiation was stimulated and bone tissue was 
formed in-vivo (Martin et al., 1997). 
Similarly, four patients suffering with SBDs were treated using a bioceramic scaffold loaded 
with autologous MSCs (previously isolated from the respective patients’ bone marrow and 
cultured in-vitro). This appeared to result in the integration of the scaffold with bone tissue 
without any negative implications, up to 7 years following the procedure.  
1.6 Hydrogels 
An alternative approach for the percutaneous delivery of cells and biomaterials to increase 
the efficacy of bone tissue regeneration is the use of hydrogels - an increasingly important 
class of highly hydrated polymers.  
Specifically, hydrogels are 3D, hydrophilic, crosslinked polymeric materials capable of 
absorbing large quantities of water or biological fluids without dissolving. This high-water 
content, partnered with porosity and soft consistency means that hydrogels replicate natural 
living tissue more accurately than other classes of synthetic biomaterials (Peppas, 2000).  
Hydrogels can be categorised according to numerous criteria: origin (natural or synthetic), 
preparation method (homopolymer, co-polymer, multipolymer or interpenetrating 
hydrogels), ionic charge and physical structure (amorphous, semi-crystalline, or hydrogen 
bonded structures; Gkioni et al., 2010). 
1.6.1 Natural 
Natural hydrogels, generally, are biodegradable, biocompatible, and promote the 
attachment and proliferation of cells in the absence of cytotoxic effects (Ghasemi-




chitosan, alginate, pullulan and agarose, and proteins, such as collagen, gelatin, and fibrin 
(Ghasemi-Mobarakeh, 2015). However, as natural hydrogels are synthesised using materials 
from living organisms, the previously mentioned immunological risks surrounding viral/prion 
transmission apply. Similarly, the speed at which natural hydrogels degrade and the degree 
of variability between batches are also problematic (Maisani et al., 2017). 
1.6.2 Synthetic 
Synthetic hydrogels negate these immunological concerns, as well as providing greater 
reproducibility of their physiochemical characteristics. Furthermore, as they are synthetically 
produced, they are available in unlimited quantities and can be modified to allow a more 
precise fit to applications (Maisani et al., 2017). Synthetic polymers used for hydrogel 
production include polyesters such as PGA, PLA, polyethylene glycol (PEG), 
polyphosphoesters, and synthetic peptides (Maisani et al., 2017). Despite their advantages, 
synthetic hydrogels of this nature lack cellular binding sites that are present in natural 
hydrogels, such as those composed of collagen or gelatin. 
1.6.3 Preparation 
In the absence of crosslinking hydrogels are known as hydrosols, which is a liquid state. 
Crosslinking of the hydrophilic polymers is therefore necessary for the fabrication of 
hydrogels. This can be via physical or chemical crosslinking.  
1.6.3.1 Physical Crosslinking 
Physical crosslinking involves intra and intermolecular interactions between polymers. 
Specifically, the polymeric chains are connected by non-covalent interactions such as ionic 
interactions, hydrogen bonds, hydrophobic effects, or via direct entanglement of polymeric 
chains (Ahmed, 2015). Crosslinking of this nature relies upon factors such as pH or 
temperature changes for initiation. Therefore, the cytocompatibility of resultant hydrogels is 




1.6.3.2 Chemical Crosslinking 
Chemical crosslinking, unlike physical crosslinking, involves the formation of irreversible 
covalent bonds between polymeric chains (Ahmed, 2015). Numerous techniques have been 
utilised to achieve covalent crosslinking, including free radical polymerisation, click 
chemistry, photo-crosslinking, Michael-type addition and enzymatic crosslinking (Gasperini 
et al., 2014; Maisani et al., 2017; Sivashanmugam et al., 2015). The commonality between 
these methods is the provision of specific chemical and physical conditions which stimulate 
the reaction between polymeric chains. However, to be considered in bone tissue 
engineering applications, potentially toxic precursors, initiators and crosslinkers must be 
removed entirely prior to use. Additionally, chemical crosslinking may result in the 
undesirable alteration of the original biological properties of the polymers (Maisani et al., 
2017). 
1.6.4 Biomedical Applications  
The first synthetic, biocompatible, hydrogel was formulated from poly-2-
hydroxyethylmethacrylate (PHEMA), intended for applications as contact lenses (Wichterle 
and Lim, 1960). Since then, the versatile nature of hydrogels, and the multitude of 
advantages which they possess, have been elucidated. These advantages include: 
injectability, precise fitting to defect sites and the incorporation of cells and bioactive 
substances, such as growth factors and enzymes, with relative ease (Douglas et al, 2012). As 
a result, hydrogels have numerous applications. For example, in controlled drug delivery 
(Hoffman, 2002) and in biosensors (Gawel et al., 2010). Importantly, in terms of bone tissue 
engineering, hydrogels can be used to synthetically replicate the architecture of the 
extracellular matrix (ECM), provide a structurally supportive temporary scaffold for cells and 
ensure efficient nutrient and gas exchange is maintained (Geckil et al., 2010). Therefore, 




differentiation of bone cells, to ultimately restore functionality to defect sites (Kondiah et al., 
2016). 
However, as hydrogels gain interest as biomaterials for utilisation in BTE, their mechanically 
stability, receptiveness to mineralisation, non-cytotoxicity and ability to support adhesion 
and growth of bone forming cells are increasingly important. Ease of sterilisation and 
antibacterial activity are also desirable properties of hydrogels in this space. Importantly, 
these properties can be enhanced by the incorporation of additives into the hydrogel. For 
example, Travan et al (2009) demonstrated the antimicrobial activity of a hydrogel 
supplemented with nanoparticles, while ceramics and carbon nanotubes have been used to 
increase the mechanical properties of hydrogels (Tozzi et al., 2002). 
1.7 Research Aims 
The aim of the present study was to investigate novel biomaterials for use in bone-tissue 
engineering. Specifically, three hydrogel materials were evaluated: 
1. Electron irradiated Gelatin hydrogels supplemented with Alkaline Phosphatase (ALP) 
2. WPI hydrogels supplemented with Carbon Nanotubes (CNTs) 
3. WPI hydrogels supplemented with Phloroglucinol (PG) 
The alkaline phosphatase enzyme (ALP) was incorporated into electron beam-crosslinked 
gelatin hydrogels to attempt to induce their mineralisation with Calcium phosphate (CaP). 
Both physiochemical and biological properties of the resultant gels were then evaluated to 
establish the effects of this process, and the suitability of these hydrogels for bone tissue 
engineering.  
CNTs and PG were incorporated into WPI hydrogels to investigate their influence on 
properties relevant for bone tissue engineering. Specifically: antibacterial properties, 




Chapter 2: Gelatin Hydrogels 
2.0 Introduction 
2.1 Biomaterial Mineralisation  
Hydrogels possess several inherent disadvantages when examined as materials to satisfy 
applications in bone tissue engineering. Their generally weak mechanical properties are one 
of the primary disadvantages, as this limits their use in non-load bearing sites (Griffith, 2000; 
Hoffman, 2002). Furthermore, hydrogels are generally unable to mineralise with calcium 
phosphate (CaP) and form durable interactions with tissues such as bone. Previously, the 
most common strategy to remedy this was the inclusion of inorganic particles, such as CaP 
ceramics, into the hydrogel matrices to act as nucleation sites and enable mineralisation 
(Douglas et al., 2012). However, this strategy usually results in the aggregation of CaP 
particles. It is often necessary, therefore, to use techniques to improve dispersion, such as 
the direct formation of CaP in the hydrogel (Leeuwenburgh et al., 2007), or the utilisation of 
dispersants such as citrate (Leeuwenburgh et al., 2010). Finally, sterilisation is often difficult 
(Neumann and Epple, 2006). 
As discussed by Douglas et al (2012), a multitude of advantages are predicted to accompany 
mineralisation. The presence of the CaP mineral can enhance the biological performance of 
bone-substituting materials by a phenomenon of bioactivity, where a chemical bond is 
formed with the adjacent bone tissue following implantation (Le Geros, 1991). Additionally, 
CaP ceramics possess an intrinsic affinity for biologically active proteins, such as growth 
factors, which are necessary for the natural healing process of bone tissue (Ruhe et al., 
2005). Furthermore, as previously mentioned, one of the primary disadvantages associated 
with hydrogels are weak mechanical properties, meaning that, without reinforcement, their 
implications are somewhat restricted to soft tissue engineering. However, the mechanical 




tissue engineering purposes, such as bone tissue regeneration (Douglas et al., 2013). 
Furthermore, mineralisation is anticipated to improve the compatibility of hydrogels with 
bone tissue, as both stiffer and rougher surfaces are known to promote the differentiation of 
cells towards the osteoblastic phenotype. Therefore, the development of mineralised 
hydrogels is desirable.  
2.1.1 Mineralisation by Incorporation of Nanoparticles 
One method to mineralise hydrogels is by directly incorporating inorganic phase 
nanoparticles. Upon integration, these inorganic phases provide nucleation sites for the 
formation of HA, in addition to adhesion sites that permit integration with adjacent bone 
tissue (Cao and Hench, 1996; Rea et al., 2004). As well as the previously mentioned benefits 
that accompany mineralisation, the incorporation of inorganic nanoparticles allows the 
manipulation of the rate at which the hydrogels degrade (Ara et al., 2002; Neumann and 
Epple, 2006). Additionally, the combination of ceramic biomaterials with hydrogels allows 
easier implantation into bone defects as the elastic properties of the hydrogel shield the 
ordinarily brittle ceramic particles (Kretlow and Mikos, 2007).  
Numerous bioactive inorganic materials can fulfil the role of mineralising hydrogels. 
However, calcium phosphates and bioglasses are used most frequently. Specifically, HA, 
amorphous calcium phosphate, and β-tricalcium phosphate as they closely resemble the 
native mineral phase of bone tissue (Dorozhkin and Epple, 2002). The incorporation of HA 
into cyclic acetal hydrogels resulted in increased expression of osteogenic signals, which 
ultimately enhanced the differentiation of bone marrow stromal cells. Therefore, implicating 
these composites in hard tissue engineering (Patel et al., 2010).  
An additional method by which hydrogel mineralisation can be achieved is via biomimetic 
mineralisation in solutions containing calcium and phosphate ions. This can be further split 




formation. Both methods, however, result in CaP crystals occupying the hydrogels, acting as 
nucleation sites, and stimulating posterior crystal growth (Douglas et al., 2013). 
2.1.2 Immersion in Calcium/Phosphate Ion Containing Solutions 
Immersion strategies are dependent on the ability of ions to enter hydrogels (which is 
permitted by their hydrated structure). Traditionally, as it is thought to replicate the in-vivo 
mineralisation behaviour of a biomaterial, simulated body fluid (SBF) was the most common 
solution used to achieve mineralisation of biomaterials (Douglas et al., 2013). Following 
treatment with calcium chloride solution, immersion in SBF for 14 days resulted in 
successful, homogenous, mineralisation of a cellulose based hydrogel (Hong et al., 2006).  
Alternative approaches include alternate soaking – the sequential immersion of hydrogels in 
solutions containing supraphysiological ion concentrations, first in a calcium ion (Ca2+) 
containing solution and then in a solution containing phosphate (PO43-), or vice versa. This 
technique does not replicate in-vivo mineralisation conditions; however, mineral is formed 
quicker, and the ability to manipulate both ion concentration and the temperature at which 
this process occurs allows the mineralisation process to be optimised. For example, Du et al 
(2000) utilised the alternate soaking method to mineralise collagen matrices.  This study also 
demonstrated that various crystal polymorphs could be formed by manipulating the method. 
Numerous additional studies have validated this technique, for example, Hutchens et al 
(2006) identified the formation of calcium deficient HA, comparable to the apatite crystals 
present in natural bone, in cellulose hydrogels exposed to this technique. The addition of 
biomacromolecules which stimulate the mineralisation process has also been found to 
enhance this process. However, the resultant mineral phase formed by alternate soaking is 





2.1.3 In-situ Formation of Calcium Phosphate Nanocrystals 
Adaptation of the aforementioned method can increase the homogeneity of hydrogel 
mineralisation. CaP nanocrystals are formed, in-situ, during hydrogel formation. 
Subsequently, these nanocrystals act as nucleation sites to promote further crystal formation 
following incubation in a mineralisation solution. For example, as discussed by Douglas et al., 
(2013) and Douglas et al., (2016), amorphous CaP and brushite was formed in the central 
interior of a gelatin hydrogel as a result of a double diffusion method – calcium chloride 
(CaCl2) and sodium phosphate (Na2HPO4) diffused into the hydrogel via separate reservoirs, 
on opposite sides of the hydrogel. This hydrogel was then incubated in SBF, which induced 
the formation of HA from the mineral phase (Douglas et al., 2016). 
2.1.4 Enzymatic Mineralisation  
However, despite the increased homogeneity of this strategy, the aggregation of CaP 
particles remains an issue. An alternative to the incorporation of CaP particles is the use of 
Alkaline phosphatase (ALP) - an enzyme involved in the mineralisation of bone in the human 
body by cleavage of phosphate from organic phosphate (Orimo, 2010). Specifically, ALP 
catalyses the hydrolysis of organic phosphoesters, increases the concentration of inorganic 
phosphate groups, locally, and ultimately results in the formation of carbonated apatite 
deposits. ALP can, therefore, be used to induce homogenous mineralisation of hydrogels and 
simultaneously increase their mechanical strength and suitability for applications in bone 
replacement. 
Previously, the successful mineralisation of poly(hydroxyethyl methacrylate) hydrogels and 
artificial self-assembling peptide amphiphile hydrogels by ALP was demonstrated (Spoerke et 
al, 2009). Furthermore, mineralisation was induced in dentine-derived collagen sheets, both 
in-vitro and in-vivo, by covalent linkage with ALP (Beertsen and Van den Bos, 1992; Van den 




which ALP was used to induce mineralisation in one natural and two synthetic hydrogel 
materials, thus, demonstrating the applicability of this approach to a wide range of 
hydrogels. The implications of ALP as a hydrogel component to directly increase bone tissue 
regeneration have been evaluated. Specifically, following covalent linkage to a fibrin gel, ALP 
induced mineral formation was observed in-vitro. Subsequently, this scaffold enhanced bone 
tissue formation in a mouse calvarial defect in-vivo (Osathanon et al., 2009).  
The basic principle of ALP mediated hydrogel mineralisation begins with the entrapment of 
the enzyme into the hydrogel during gelation. Once incorporated, the hydrogel is soaked in a 
solution containing glycerophosphate (GP) and Ca2+ (substrates for ALP). These substrates 
diffuse into the hydrogel, where ALP cleaves the phosphate (P) from GP. Subsequently, free 












Figure 4: The process of enzymatic mineralisation of hydrogels with Calcium Phosphate. 
Ca-GP diffuses into hydrogels supplemented with ALP resulting in cleavage of 
glycerophosphate (GP) to phosphate (P) by ALP. Free P then reacts with Calcium ions to 




2.2 Gelatin  
The present study utilised this ALP mediated approach to mineralise hydrogels comprised of 
gelatin. Previously, gelatin based materials have shown promise as biomaterials for 
applications in bone tissue engineering. Gelatin is a mixture of proteins obtained by either 
acid or alkaline hydrolysis of collagen – the primary component in the ECM, skin, tendons 
and all other connective tissues (Harrington and Von Hippel, 1962). Therefore, it is 
inexpensive and widely available in nature. Moreover, it has exceptional biocompatibility, is 
not immunogenic, is biodegradable and has the capacity to be modified at the amino acid 
level (Liu et al, 2009). The ability of gelatin to promote cellular growth has also been 
previously established (Wisotzki et al., 2016).  All of which make gelatin an ideal biomaterial 
for tissue engineering. 
However, gelatin hydrogels lose integrity at body temperature without crosslinking. Thus, 
providing an obstacle for its applications in bone tissue engineering. Conventional 
crosslinking methods involve the use of potentially toxic chemical crosslinkers, such as 
glutaraldehyde (GTA), which detract from the previously mentioned advantages. Specifically, 
unreacted GTA, as well as GTA released via degradation, has been demonstrated to increase 
cytotoxicity and reduce cellular growth (Jayakrishnan and Jameela, 1996; van Luyn et al., 
1992). Reagent free crosslinking methods are, therefore, desirable. Both gamma and 
ultraviolet (UV) radiation have been implicated, however, negatives such as uneven 
transmission through the gelatin layers (UV) and the long exposure time required to achieve 
high doses (gamma) accompany these techniques (Wisotzki et al., 2014). More recently, 
crosslinking via electron irradiation has been elucidated as a quick yet effective crosslinking 
technique.  Further advantages include the manipulation of penetration depth by altering 
electron energy, and the fact that electron irradiation, even at low doses (several KiloGrays 




Specifically, Wisotzki et al (2016) evaluated the potential cytotoxicity of electron irradiated 
gelatin hydrogels on fibroblast cells. No significant increase in cell death was observed, even 
at doses of 60kGy. However, cell viability and proliferation rates were reduced slightly, in a 
dose-dependent manner. Therefore, overall, implicating gelatin hydrogels crosslinked by this 
method in tissue engineering.  
Thus, the present study combines the previously elucidated method of ALP mediated 
mineralisation with electron irradiation to produce gelatin hydrogel composites with 
increased suitability for applications in bone tissue engineering. Specifically, mechanical 
strength, mineralisation and cytocompatability were evaluated. 
 
3.0 Methods 
3.1 Hydrogel Preparation 
Hydrogel preparation was carried out by Stefanie Riedel (Leibnitz Institute of Surface 
Modifications, Germany). First, type I gelatin powder (G2500; Sigma-Aldrich Chemie GmbH, 
Germany) was dissolved in deionised water, resulting in a concentration of 8mg/ml. Alkaline 
phosphatase (ALP; P7640; Sigma-Aldrich, Germany) was then added (with concentrations of 
0, 1.25, or 2.5 mg/ml). Subsequently, the gelatin-ALP solution was left to swell for one hour 
at room temperature before being heated to 37°C with simultaneous stirring to ensure the 
solution was dissolved homogenously. The solution was then poured into the desired moulds 
and left to polymerise for 12 hours, at 6°C. 
3.2 Hydrogel Preparation ‘Thick’ and ‘Thin’ 
To evaluate whether the thickness of mineralised gelatin hydrogels influences their 




gelatin hydrogels. Different moulds were used to produce samples 8mm and 2mm in height, 
respectively.  
3.3 Electron Irradiation  
Electron Irradiation was carried out by Stefanie Riedel (Leibnitz Institute of Surface 
Modifications, Germany). Following polymerisation, samples were prepared for electron 
irradiation. Briefly, they were inserted into airtight bags which were flushed with nitrogen 
and sealed. Simultaneous crosslinking and sterilisation of samples was subsequently carried 
out, as they were irradiated with electrons by a linear electron accelerator (MB10-30MP; 
Mevex, Ontario, Canada) with doses ranging from 5 to 40kGy, in steps of 5 kGy. The electron 
accelerator was operated with a moving state at a repetition rate of 180Hz, a scanning 
frequency of 3Hz, and an electron pulse length of 8µm. During this process, samples were 
cooled by an air draft to prevent heating. The irradiation dose was verified (to an accuracy of 
10%) by a graphite dosimeter.  
3.4 Mineralisation of Hydrogels 
Hydrogel mineralisation was performed by Stefanie Riedel (Leibnitz Institute of Surface 
Modifications, Germany). Resultant hydrogels were mineralised in accordance with the 
previously published protocol by Douglas et al (2012). Briefly, resultant hydrogels were 
incubated in 0.1M calcium glycerophosphate (CaGP) in H2O for 6 days – medium was 
changed every 24 hours. Ultrapure H2O was then used to rinse the hydrogels three times, 






3.5 Dry Mass Percentage: 
To determine the ratio of mineralised material, samples were weighed in the hydrated state, 
dried for 24 hours at 60°C, and weighed again. Dry mass percentage was then calculated 
using the following equation.  
 
Dry mass %  = # !"#$%&	#(	)*+	,&-&"
!"#$%&	#(	%+)*-&")	,&-&"
$ x 100 
 
3.6 Compression Modulus Analysis 
The compressive modulus of samples was determined by Stefanie Riedel (Leibnitz Institute 
of Surface Modifications, Germany) using a universal testing machine (Inspekt mini; 
Hegewald & Peschke Meß- und Prüftechnik GmbH, Germany), with a 100 Newton (N) load 
cell to measure the applied force. The displacement rate was set at 2mm per minute until 
sample failure was reached. Compressive stress (𝜎𝐶) was then determined using the applied 
force and the cross-sectional area: 𝜎𝐶=𝐹/𝐴. Then, the compression modulus can be 
determined by the gradient of the linear-elastic range of the stress-strain curve for small 
strains. 
3.7 Raman Spectroscopy 
Raman spectroscopy was utilised to provide a structural fingerprint of the gelatin hydrogels, 
to allow subsequent identification of their molecular structures and chemical composition. 
Raman spectra were collected using a Renishaw inVia Raman Spectrometer (Renishaw Plc., 
UK) using an excitation wavelength of 785 nm. The laser power was ~15 megawatts (mW) at 
the sample, and spectral acquisition time was 5 seconds x 12, resulting in a total exposure 




To compare spectra directly, cosmic ray removal, baseline correction and smoothing were 
carried out using MATLAB software (The MathWorks, USA). Smoothing was applied using a 
triangular sliding average and baseline correction was applied using an asymmetric least 
squares algorithm. 
3.8 Fourier-Transform Infrared Spectroscopy (FT-IR) 
The molecular structure of the gelatin hydrogels was examined using an Agilent Technologies 
Cary 630 FT-IR machine, equipped with a diamond crystal, in attenuated total reflectance 
mode (ATR) and using microlab software. Spectra were recorded over a wavenumber range 
of 500cm-1 to 4000cm-1. 
3.9 Scanning Electron Microscopy (SEM) 
SEM analysis was performed using a 7800F JEOL SEM instrument. 
Prior to SEM analysis, samples were mounted on aluminium stubs (Agar scientific Ltd, UK) 
using carbon adhesive pads (Agar Scientific Ltd, UK) and coated with a thin layer of gold (ca. 
10nm) using a Q150RES sputter coater (Quorum Technologies Ltd). 
3.10 Cell Culture Sample Preparation for Scanning Electron Microscopy 
Following cell culture, samples were also visualised by SEM to allow a more detailed 
evaluation of the surface topography of the hydrogels, cell morphology and attachment to 
the surface of the samples. 
First, at the relevant time points (1, 4 and 7 days), the samples were fixed for a minimum of 2 
hours, in 4% Glutaraldehyde.  Samples were then subject to a series of dehydration steps 
with ethanol (Fisher Scientific, UK). Samples were placed in 70%, 80%, 90% ethanol, 
sequentially, and then in 100% ethanol twice, for 20 minutes each. Subsequently, samples 




being placed in fresh HMDS and left in the fume cupboard in an open vial, to allow the HMDS 
to sublimate. 
Once dry, samples were mounted on aluminium stubs (Agar scientific Ltd, UK), using carbon 
adhesive pads (Agar Scientific Ltd, UK), and coated with a thin layer of gold using an S150A 
sputter coater. Coating was carried out at 40mA, under 1.5 bars of pressure for 5 minutes. 
Samples were subsequently examined using a JEOL JSM-5600 instrument (JEOL Ltd, Japan). A 
spot size of 14, and an acceleration voltage of 15 was used. 
3.11 Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
Since ICP-OES is a more reliable method to evaluate the elemental composition of the 
mineralisation product, the Calcium and Phosphorus concentrations, as well as the calcium 
to phosphorus ratio, were determined using a 5100 Synchronous Vertical Dual View optical 
emission spectrometer (Agilent Technologies, USA). Prior to analysis, hydrogels were dried, 
dissolved in 3ml of 14 Molar (M) Nitric acid (HNO3; Fisher Scientific, UK), then further diluted 
(1 in 100) using 0.3 M HNO3. 7 standard solutions, with calcium (Fisher Scientific, UK) and 
phosphorus (Alfa Aesar, UK) concentrations ranging from 0 to 250mg/L, were used to 
calibrate the instrument. Additionally, all solutions contained Yttrium (Sigma-Aldrich, USA), 
which was utilised as an internal standard to account for exogenous effects. Measurements 
were taken in triplicate.  
3.12 Cell Culture 
To evaluate the interaction of the gelatin hydrogels with bone cells, a human osteosarcoma 
(MG-63) cell line (Sigma-Aldrich, USA) was seeded on to the hydrogels.  At intervals of 1, 4 
and 7 days, the adhesion, proliferation, and morphology of cells was assessed by fluorescent 
microscopy, while cell viability was evaluated via the MTS assay.  
Specifically, MG-63 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 




Streptomycin (50-100IU/ml and 50-100µg/ml, respectively), at 37°C, with 90% humidity and 
5% atmospheric pressure of carbon dioxide (CO2).  
Hydrogels were cut into thin slices and placed into 48-well plates (Corning Incorporated, 
USA). Subsequently, 1ml of DMEM culture media containing 5000 cells was added to each 
well (5263 cells/cm2 growth area). Once the cells were seeded, the hydrogels were incubated 
at 37°C, with 90% humidity and 5% atmospheric pressure of CO2 once again.  
3.12.1 Fluorescent Microscopy 
At the appropriate time point (1, 4 and 7 days) samples were washed with phosphate 
buffered saline (PBS), and subsequently fixed with 70% ethanol (Fisher Scientific, UK) at -
20°C for 10 minutes. Samples were then washed again with PBS before staining.  
Samples were stained with Hoechst and Texas red (both Sigma-Aldrich, USA) diluted in PBS 
at concentrations of 500ng/ml and 50ng/ml, respectively, for 15 minutes in dark conditions. 
Hoechst binds to the minor groove of double DNA, with affinity for adenine and thymine rich 
sequences. Thus, Hoechst is used to stain the cell nucleus. The Hoechst stain is excited in the 
UV range (approximately 361nm) and emits blue fluorescence around 497nm. Texas Red is 
used to stain the cytoplasm, as it binds to reduced thiol groups which are present in 
cytoplasmic proteins. The maximal excitation is approximately 596nm, while the optimal 
emission is around 615nm (observed as red). 
After staining, samples were washed twice with PBS and subsequently visualised on an Axio 
Scope.A1 microscope (Zeiss, Germany) using a digital camera and Zeiss software. 
3.12.2 Proliferation (MTS) Assay 
The MTS assay was used to assess the proliferation of MG-63 cells on each of the hydrogel 
sample groups at the appropriate time points (1, 4 and 7 days). Briefly, this method indirectly 
measures proliferation, cell viability and cytotoxicity since viable, metabolically active cells 




mitochondrial dehydrogenase enzyme named succinate tetrazolium reductase produced by 
metabolically active cells. The concentration of this insoluble formazan can then be 
quantified by spectrophotometry 
DMEM, without phenol red, and supplemented with 10% FBS was used to dilute the MTS Cell 
Titer 96 Aqueous one solution cell proliferation assay kit (Promega, USA) by a factor of 1:6. 
Three independent samples for each sample group and time interval were included in the 
assay, along with a polystyrene plate (Corning Incorporated, USA) as a control sample. One 
sample without cells for each sample group and time interval was used to measure a 
background of the materials. First, samples were washed with PBS, transferred to a new well 
plate to remove interference from cells attached to the base of the polystyrene plate wells, 
and then incubated for 2 hours at 37°C with 90% humidity and 5% atmospheric pressure of 
CO2, in 0.5ml of the diluted MTS solution.  
After the 2-hour incubation, 100 µl of the solution from each well was transferred, in 
triplicate, to a 96-well plate to allow the extent of the yellow tetrazolium dye reduction to 
violet formazan to be quantified by a spectrophotometer (Tecan Infinite M200 Pro, 











Sample Abbreviation Description 
0mg/ml ALP in ddH2O Electron irradiated Type I gelatin (40kGy unless stated 
otherwise), 0mg/ml ALP, incubated in ddH2O. 
0mg/ml ALP in CaGP Electron irradiated Type I gelatin (40kGy unless stated 
otherwise), 0mg/ml ALP, incubated in 0.1M CaGP for 6 days 
prior to rinsing. 
1.25mg/ml ALP in CaGP Electron irradiated Type I gelatin (40kGy unless stated 
otherwise), 1.25mg/ml ALP incubated in 0.1M CaGP for 6 
days prior to rinsing. 
2.5mg/ml ALP in CaGP Electron irradiated (40kGy unless stated otherwise) Type I 
gelatin, 1.25mg/ml ALP incubated in 0.1M CaGP for 6 days 
prior to rinsing. 
Thick As above, 8mm in height 




4.1 Dry Mass Percentage: 
The percentage of hydrogel mass, not consisting of water, for gelatin hydrogels with ALP 
concentrations of 0, 1.25 and 2.5 mg/ml, exposed to radiation doses of 0, 5, 10, 15, 20 and 
40 kGy, is illustrated in figure 5.  
The dry mass percentage of samples at each concentration of ALP increased due to electron 
irradiation. Statistically significant increases in dry mass percentage were observed, for each 
sample group (0mg/ml ALP in ddH2O, 0mg/ml ALP in CaGP, 1.25mg/ml ALP in CaGP, and 
2.5mg/ml ALP in CaGP) when the irradiation dose was raised from 0kGy to 40kGy. From 0kGy 
to 5kGy, and 5kGy to 10kGy, this increase followed a somewhat linear trend. After this point, 
however, the increase started to plateau. This was more apparent in the samples containing 
higher concentrations of ALP (1.25 and 2.5 mg/ml). For example, there was no significant 
difference in the dry mass percentages of 1.25 mg/ml ALP samples exposed to electron 
irradiation doses of 10, 15, or 20kGy.   




However, statistically significant increases in the dry mass percentages were observed when 
ALP concentrations were raised from 0 to 1.25 mg/ml, and again from 1.25 to 2.5 mg/ml, at 

















Figure 5: Dry Mass percentages of gelatin hydrogels with ALP concentrations of 0, 1.25 
and 2.5mg/ml, at electron irradiation doses ranging from 0 to 40 kGy, mineralised for 6 



















0 mg/ml ALP in dH20 0 mg/ml ALP in Ca-GP




4.2 Compression Modulus 
The compression modulus of gelatin hydrogels with ALP concentrations of 0, 1.25 and 2.5 
mg/ml, exposed to radiation doses of 0, 5, 10, 15, 20 and 40 kGy, is illustrated in figure 6. 
Hydrogels were subject to compressive testing until failure. The compressive stress was 
calculated, and the compression modulus was subsequently determined.  
Although the compression modulus of both the 0 mg/ml in ddH2O, and 0 mg/ml in CaGP 
increased alongside each subsequent elevation of the electron irradiation dose (0 to 40 kGy), 
a one-way ANOVA with Tukey’s post hoc analysis identified no statistical significance. For the 
1.25 and 2.5 mg/ml ALP samples, however, a statistically significant increase in the 
compression modulus was identified when the samples were exposed to 40 kGy compared 
to the 0 kGy control (increases of 11,486 and 11,266 kPa, respectively).  
However, for both the 1.25 and 2.5 mg/ml ALP samples, an increase in radiation from 10 kGy 
to 15 or 20 kGy resulted in a decrease in the compression modulus. For 1.25 mg/ml ALP 
samples, those exposed to 10 kGy displayed a statistically significant elevation in 
compression modulus compared to the 40 kGy exposed group. This trend was not shown in 
the 2.5 mg/ml ALP samples, as compression modulus recovered from the reduction 
displayed at 15 and 20 kGy to demonstrate an increase (although not significant) of 870 kPa 
when compared to the 10 kGy samples. 
At each dose of electron irradiation, 0 mg/ml ALP samples in ddH2O displayed higher 
compression moduli than the 0 mg/ml samples in CaGP, although these discrepancies were 
not deemed statistically significant. Raising the ALP concentration from 0 mg/ml to 1.25 
mg/ml resulted in a statistically significant increase in the compression modulus observed for 
the samples at all the electron irradiation doses examined, apart from 0 kGy (5, 10, 20 and 
40 kGy); while the highest concentration (2.5 mg/ml) resulted in a statistically significant 




Although the compression moduli of samples at 2.5 mg/ml ALP were elevated compared to 
the 1.25 mg/ml ALP samples at doses of 0 and 40 kGy of electron irradiation, no statistical 
significance was identified. However, at the remaining irradiation doses (5, 10, 15 and 20 
kGy), the compression moduli of samples containing ALP at concentrations of 1.25 mg/ml 





































0 mg/ml ALP in dH2O 0 mg/ml ALP in Ca-GP
1.25 mg/ml ALP in Ca-GP 2.5 mg/ml ALP in Ca-GP
Figure 6: Compression modulus of gelatin hydrogels with ALP concentrations of 0, 1.25 
and 2.5mg/ml, at electron irradiation doses ranging from 0 to 40 kGy.  Subject to 





4.3 Raman Spectroscopy 
Raman spectroscopy utilises vibrational, rotational, and other low frequency modes in a 
system to provide a structural fingerprint which enables molecular identification.  
No significant bands, typical of molecules of interest, were detected via the Raman spectra 
(figure 7) for the gelatin control samples (0 mg/ml ALP in ddH2O). Similarly, the spectra for 
the 0 mg/ml ALP in CaGP group were unremarkable, except for a relatively low intensity peak 
at approximately 1035 cm-1, typical of v1PO43-. However, high intensity bands typical of PO43- 
groups were detected for both gelatin samples containing ALP (1.25 and 2.5 mg/ml ALP in 
CaGP).  
Specifically, Raman bands characteristic of the v1 stretching of PO43- groups were detected at 
approximately 957 cm-1. The intensity of this band approximately doubled when ALP 
concentration was increased from 1.25 mg/ml to 2.5 mg/ml. Additional bands were detected 
at around 1242 cm -1, characteristic of Amide III groups – specifically the protein β-sheet and 
random coils, and ~1446 cm-1, characteristic of protein CH2 deformation; both of which were 
more intense at 2.5 mg/ml ALP. Furthermore, bands characteristic of collagen proline (v(C-






























Figure 7: Baselined-corrected Ram
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4.4 Fourier Transmission Infrared Spectroscopy (FT-IR) 
FT-IR spectra for all composites subject to incubation in CaGP displayed double bands 
characteristic of the v4 vibrations of PO43- groups in the region of 563-603cm-1, which were 
absent in the control (0mg/ml in ddH2O). This double band is more obvious at ~540cm-1, with 
the second band at ~600cm-1 less apparent. Strong absorption bands characteristic of PO43- 
stretching were also present at ~970 cm-1 and between 1045 to 1100cm-1 in the spectra for 
samples containing ALP but absent in the control. However, the spectra for the CaGP control 
(0mg/ml ALP) displayed two bands in this region. A weak band at ~870cm-1 derived from the 
v5 P-O(H) deformation of HPO42- groups was also present in both ALP supplemented 
composites (1.25 and 2.5mg/ml) but did not appear to be present in either of the control 
groups (Van Den Vreken et al., 2006).  
Strong bands in the region of ~1200-1700cm-1 representative of overlapping signals of N-H 
bending and C=O and C-N stretching typical of the Amide I and Amide II bands found in 
proteins were observed in the 0mg/ml ALP ddH2O control. These bands were far less 
pronounced in the remaining sample groups. 
It was also noted that the relative intensities presented on the spectra was unexpected, with 
both the 0mg/ml ALP CaGP and 1.25mg/ml ALP samples exhibiting elevated absorbance 




















4.5 Scanning Electron Microscopy (SEM) 
SEM was utilised to analyse differences in the surface topography of gelatin hydrogels with 
ALP concentrations ranging from 0 to 2.5 mg/ml, following 6 days of mineralisation in CaGP 
(figure 9).  
The unmineralized ALP/CaGP-free gelatin control samples (A) displayed a consistently 
smooth surface topography. The surfaces of the 0 mg/ml ALP in CaGP samples were also 
relatively smooth in appearance. However, their surface displayed a less consistent 
morphology as sporadic deposits and ‘rougher’ sections could be visualised (figure 9B). 
Despite this, both ALP-free sample groups were markedly different to the ALP mineralised 
samples, which presented a considerably rougher surface morphology. 
SEM imaging of both 1.25 and 2.5 mg/ml ALP samples demonstrated successful ALP-induced 



















0 ALP ddH2O 0 ALP CaGP 1.25 ALP CaGP 2.5 ALP CaGP
Figure 8: FTIR spectra of Electron Irradiated Gelatin hydrogels incorporated with ALP, 




distributed homogenously across the surface of the gelatin samples, with typical diameters 
of 100 to 500 nm.  
SEM was perhaps insufficient to allow the elucidation of morphological discrepancies 


















Figure 9: SEM Images of gelatin hydrogels containing ALP concentrations of 0 mg/ml in 
ddH2O (A), 0 (B), 1.25 (C) and 2.5 (D) mg/ml mineralised for 6 days in CaGP. Images 






4.6 Cell culture Scanning Electron Microscopy 
To allow a more detailed assessment of the morphology and attachment of cells onto the 
hydrogel samples following cell culture, samples were visualised by SEM (as illustrated in 
figure 10). Following 7 days of cell culture, confluent layers of cells could be visualised on the 
control (0 mg/ml ALP in ddH2O samples [Ai and Aii]). Cells were spread with clearly defined 
borders and visible filopodia present, suggesting effective attachment. Similarly, large areas 
with complete cell coverage were observed in the remaining ALP-free sample group (0 
mg/ml ALP in CaGP [Bi and Bii]). Again, filopodia could be seen, and attachment to the 
hydrogel surface appeared to be good. However, areas of the hydrogel without cell coverage 
could also be observed.  
As the ALP concentration increased, first to 1.25 (Figure 10 Ci and Cii) and then 2.5 mg/ml (Di 
and Dii), the areas of the hydrogels with cell coverage became more sporadic. On the 1.25 
mg/ml hydrogels, layers of cells which appear to have been (previously) confluent could be 
observed. Spread cells could still be observed, but they were also accompanied by a greater 
proportion of cells which appeared to be peeling from the surface, or cells which appear to 
have been lysed (Cii). These observations remained consistent when the 2.5 mg/ml samples 
(Di and Dii) were imaged. However, the proportion of cell coverage was again reduced, while 




























Figure 10: SEM images of gelatin hydrogels containing ALP concentrations of 0 mg/ml 
in ddH2O (Ai and Aii), (Bi and Bii), 1.25 (Ci ad Cii) and 2.5 (Di and Dii) mg/ml 
mineralised for 6 days in CaGP, after the 7th day of cell culture. Images show scale bars 








4.7 Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
ICP-OES was utilised to obtain a more accurate determination of the extent to which 
mineralisation had been successfully induced by ALP. The elemental composition of the 
mineralisation product, P and Ca concentrations, and the Ca:P ratio was determined.  
4.7.1 Phosphorus Concentration 
Only negligible traces of elemental P were detected in the ALP/CaGP-free gelatin control 
group. A statistically significant increase (p<0.05) in elemental P concentration was observed 
when the ddH2O was replaced with CaGP, even when the ALP concentration remained at 0 
mg/ml. However, when the concentration of ALP was raised to 1.25 mg/ml, and further to 
2.5 mg/ml, statistically significant increases (p<0.001) in the mean elemental P concentration 
of samples was observed (83.15mgP/g and 93.35mgP/g, respectively). Although the 
observed P concentration of samples containing 2.5 mg/ml ALP was elevated compared to 














4.7.2 Calcium Concentration 
The same trend was observed for elemental Ca concentration (figure 12). No notable 
concentration of Ca was identified in 0mg/ml ALP in ddH2O samples. This increased, in a 
statistically significant manner (p<0.05), to a mean Ca concentration of 20.54 mg/g in 0 
mg/ml ALP in CaGP samples. Similarly, mean Ca concentrations displayed statistically 
significant increases (p<0.001) when ALP concentrations were raised to 1.25 and 2.5 mg/ml 
(155.91 and 177.30 mg/g sample, respectively). The mean increase of 21.39 mg/g observed 
Figure 11: ICP-OES determination of Phosphorus concentrations of gelatin hydrogels 
with ALP concentrations of 0, 1.25 and 2.5mg/ml, electron irradiated at 40kGy, 
following 6 days of enzymatic mineralisation. One-way ANOVA was performed. Results 
expressed as means ± standard deviation. Differences considered significant if p≤0.05. ‘*’ 
relates to the significant difference between groups exposed to CaGP and the ddH2O 
control (*** P<0.001, * P<0.05). ‘#’ relates to the significant difference between 
































when ALP concentration was elevated from 1.25 to 2.5 mg/ml, was also statistically 













4.7.3 Molar Ratio 
The molar Ca:P ratio, determined by ICP-OES, is illustrated in figure 13. All observed Ca:P 
ratios were lower than that of stoichiometric hydroxyapatite (1.67).  
ALP/CaGP-free samples displayed a mean Ca:P ratio of 0.82. This increased to 1.11 in ALP 
free samples soaked in CaGP and increased further in samples containing 1.25 and 2.5 mg/ml 
ALP (1.23 and 1.27, respectively), all of which displayed statistical significance (p<0.05) 
compared to the ALP/CaGP free control. However, differences in the molar ratios between 






















Figure 12: ICP-OES determination of calcium concentrations of gelatin hydrogels with 
ALP concentrations of 0, 1.25 and 2.5mg/ml, electron irradiated at 40kGy, following 6 
days of enzymatic mineralisation. One-way ANOVA was performed. Results expressed as 
means ± standard deviation. Differences considered significant if p≤0.05. ‘*’ relates to the 
significant difference between groups exposed to CaGP and the ddH2O control (*** 
P<0.001, * P<0.05). ‘#’ relates to the significant difference between experimental groups 
















4.8 Fluorescent Microscopy (Experiment One)  
The interaction of gelatin hydrogels, containing ALP and mineralised for 6 days, with a 
human osteosarcoma (MG-63) cell line was evaluated at intervals of 1, 4 and 7 days. The 
adhesion, proliferation, and morphology of cells was assessed by fluorescent microscopy, as 
illustrated in figure 14. Cell nuclei were successfully stained (blue) with Hoechst, while the 
cytoplasmic regions of cells were successfully stained (red) with Texas Red. 
No definitive conclusions can be drawn from the results of fluorescent microscopy, as 
expression levels were not quantified, p-values were not obtained, and therefore no 
statistical significance can be suggested. However, as illustrated in figure 14, after 24 hours 

























* * * 
Figure 13: ICP-OES determination of Ca/P molar ratio of gelatin hydrogels with ALP 
concentrations of 0, 1.25 and 2.5mg/ml, electron irradiated at 40kGy, following 6 days 
of enzymatic mineralisation. One-way ANOVA was performed. Results expressed as 
means ± standard deviation. Differences considered significant if p≤0.05. ‘*’ relates to the 





the sample groups (ALP/CaGP control, 0, 1.25 and 2.5 mg/ml ALP in CaGP hydrogels). On 
each group, both the cytoplasm and nuclei of cells were well defined, while cells portrayed a 
healthy, well spread morphology. However, cells appeared more numerous in the gelatin 
control sample, where an almost confluent layer of cells was observed. The number of cells 
visible by microscopy appeared to reduce, first when ddH2O was substituted with CaGP, and 
then further with each increase of sample ALP concentration.  
These observations appeared consistent at both 4 and 7 days of cell culture. In both sample 
groups for which ALP was absent, the number of visible cells seemed to remain relatively 
consistent from the first to the seventh day of cell culture. Similarly, the nuclei and 
cytoplasm of the visualised cells remained well defined. However, for samples containing 
ALP (1.25 and 2.5 mg/ml), the number of cells visible via fluorescent microscopy appeared to 
decrease further with each consecutive time point, with minimal cell coverage after 7 days, 
particularly in the samples containing 2.5 mg/ml ALP. Additionally, the observed cells 
































1 day                                                4 days                                              7 days 
A) 
Figure 14:  Fluorescent microscopy of MG-63 osteoblast-like cells cultured on gelatin 
hydrogels with varying ALP concentrations.  A) 0mg/ml + H2O, B) 0mg/ml , C) 1.25mg/ml  
(D) 2.5mg/ml. Samples (B,C,D) mineralised in CaGP solution and electron irradiated at 
40kGy at 1, 4 and 7 days. Cells stained by Hoechst (nuclei, blue) and Texas Red (cell 







4.9 Proliferation (MTS) Assay (Experiment One) 
The MTS assay (figure 15) was utilised to allow a quantitative evaluation of the previously 
discussed cell culture results, by measuring the extent to which metabolically active cells 
have converted a soluble tetrazolium salt into insoluble formazan – thus, indirectly 
measuring proliferation and cell viability, and cytotoxicity of the samples.  
As illustrated in figure 15, a statistically significant reduction in metabolic activity from MG-
63 cells was observed for each of the sample groups compared to the polystyrene control, at 
each time point (1, 4 and 7 days). After 24 hours of cell culture the absorbance due to the 
insoluble formazan was almost identical for the ALP-free samples (in ddH2O & in CaGP), 
measured at 0.0227 and 0.0229 a.u, respectively. Although this was approximately 11 times 
lower than the polystyrene control at the same time point. The absorbance reduced further 
with increasing ALP concentration, to 0.00586 at 1.25 mg/ml, and 0.00508 a 2.5 mg/ml ALP. 
In fact, no significant difference in metabolic activity was observed between 1.25 and 2.5 
mg/ml ALP at 1, 4 and 7 days, and both ALP-free samples after 1 day. Despite this, the 
absorbance displayed a statistically significant increase for both ALP-free samples after 4 
days. The maximum absorbance recorded for experimental samples was recorded at 0.277 
a.u for the 0 mg/ml ALP samples in CaGP after 7 days – a significant increase from that 
observed after 4 days. However, this showed no statistically significant increase compared to 





































Figure 15: Proliferation of MG-63 osteoblast-like cells on gelatin hydrogels with ALP 
concentrations of 0, 1.25 and 2.5mg/ml, mineralised in CaGP solution and electron 
irradiated at 40kGy. Assessed at 1, 4 and 7 days, via the MTS assay (as per method). 
Hydrogels were placed in 500µl of MTS solution and incubated for 2 hours. Absorbance 
was then measured via a spectrophotometer (at 490nm). # All indicates statistical 
significance within sample groups (P<0.05). *All/4,7 indicates statistical significance 
compared to the Polystyrene control at the corresponding time periods (P<0.05). Error 






























































4.10 Fluorescent Microscopy (Experiment Two) 
To supplement the previously discussed analysis of the interaction between mineralised 
gelatin hydrogels with the MG-63 cell line, the experiment was repeated using both ‘thick’ 
and ‘thin’ hydrogels, to elucidate any potential effects that hydrogel thickness may have on 
the adhesion, proliferation and morphology of cells. As illustrated in figure 16 the nuclei of 
cells were successfully stained (blue) with Hoechst stain, and the cytoplasm of cells were 
successfully stained (red) with Texas Red. 
Figure 16 depicts fluorescent microscopy images taken from samples on the seventh day of 
cell culture. Successfully cultured MG-63 cells were observed on all sample groups 
(ALP/CaGP control, 0, 1.25 and 2.5 mg/ml ALP in CaGP hydrogels), both ‘thick’ and ‘thin’, 
after 7 days of cell culture. However, cell coverage appeared to be superior on the ‘thin’ 
samples, where a seemingly confluent layer of cells appeared to cover the surface of the 
hydrogels for each sample group, including the 1.25 and 2.5 mg/ml ALP samples. Cells 
appeared to display a spread morphology, with clearly defined nuclei. The gelatin control 
hydrogels in the ‘thick’ category also displayed good cell coverage (although not confluent as 
with the thin samples), similarly, with a seemingly healthy morphology. However, increasing 
the ALP concentration to 1.25 and 2.5 mg/ml appeared to have a negative effect on cell 
proliferation, as fewer cells were observed, more sporadically, the higher the concentration 
of ALP. Additionally, the morphology of the observed cells appeared less spread and well 




























Thick (8 mm)                                Thin (2 mm) 
Gelatin 
0 mg/ml +  
CaGP 
1.25 mg/ml +  
CaGP 
2.5 mg/ml +  
CaGP 
Figure 16:  Fluorescent microscopy of MG-63 osteoblast-like cells cultured on ‘Thick’ 
and ‘Thin’ gelatin hydrogels with ALP concentrations of 0, 1.25 and 2.5mg/ml. 
Mineralised in CaGP solution and electron irradiated at 40kGy following 7 days of cell 
culture. Cells stained by Hoechst (nuclei, blue) and Texas Red (cell cytoplasm, red). Scale 




4.11 Proliferation (MTS) Assay (Experiment Two) 
Again, the MTS assay (figure 17) was utilised to evaluate the proliferation, cell viability and 
cytotoxicity of ‘thick’ and ‘thin’ gelatin hydrogel samples, in a quantitative manner. 
As illustrated in figure 17, no statistically significant difference (p<0.05) in metabolic activity 
from cultured MG-63 cells was observed between any of the sample groups, or the 
polystyrene control, after 24 hours. The observed absorbance due to insoluble formazan 
increased for each sample group from day 1 to day 4 of cell culture. Again, the values 
observed for both 0 mg/ml ALP in ddH2O (0.431 a.u) and 0 mg/ml ALP in CaGP (0.462 a.u) 
‘thin’ samples displayed no statistically significant difference compared to the polystyrene 
control after 4 days of cell culture (0.519 a.u). However, the absorbance for all remaining 
sample groups (1.25 and 2.5 mg/ml ALP in CaGP, both ‘thick’ and ‘thin’ and ALP-free ‘thick’ 
samples) demonstrated a statistically significant reduction compared to the polystyrene 
control. For the ‘thin’ samples, increasing the ALP concentration from 1.25 to 2.5 mg/ml 
reduced the observed absorbance from 0.264 to 0.239 a.u, although this was not statistically 
significant. Both observed values were increased compared to their ‘thick’ counterparts. 1.25 
mg/ml ALP samples demonstrated a negligible 0.007 increase in the ‘thin’ samples compared 
to the thick. A statistically significant increase was observed in the 2.5 mg/ml ALP samples, 
however, which increased by 0.159 from 0.0796 (‘thick’) to 0.239 (‘thin’). After 7 days of cell 
culture, all sample groups, both ‘thick’ and ‘thin’ displayed a statistically significant reduction 
in metabolic activity compare to that of the polystyrene control at the same time point. 
Unexpectedly, the results observed for MTS following 7 days of cell culture contrast those of 
previous time points, along with the assumptions drawn from fluorescent microscopy. The 
metabolic activity observed from each sample group was increased in the ‘thick’ hydrogels 
than in its ‘thin’ counterpart, all of which were statistically significant increases, except for 























Figure 17: Proliferation of MG-63 osteoblast-like cells on both ‘thick’ and ‘thin’ gelatin 
hydrogels with ALP concentrations of 0, 1.25 and 2.5mg/ml, electron irradiated at 
40kGy. Assessed at 1, 4 and 7 days, via the MTS assay (as per method). Hydrogels were 
placed in 500µl of MTS solution and incubated for 2 hours.  Absorbance was then 
measured via a spectrophotometer (at 490nm). # indicates statistical significance for 
values within sample groups (P<0.05). * indicates a statistically significant difference 
compared to the polystyrene control (P<0.05). ‘Thi’ and ‘Thk’ indicate a statistically 
significant difference between the Thick sample group and their ‘Thin’ counterpart, at the 






























































































































As previously stated, hydrogels have numerous potential advantages in tissue engineering. 
One of which is the ease of incorporation of bioactive substances such as enzymes. Gelatin is 
a promising biomaterial, being inexpensive, biocompatible, non-immunogenic, and 
biodegradable. However, in the absence of crosslinking, hydrogels comprised of gelatin lose 
structural integrity at body temperature. This study aimed to demonstrate the utilisation of 
electron beam irradiation to simultaneously crosslink and sterilise gelatin hydrogels, while 
avoiding the use of cytotoxic chemical crosslinkers such as glutaraldehyde. Furthermore, in 
this study, the enzyme ALP was incorporated into the electron beam-crosslinked gelatin 
hydrogels to induce their mineralisation with CaP and elicit the numerous advantages 
associated with this. Mineral formation itself, along with its effects on both the morphology 
and mechanical properties of the electron irradiated gelatin hydrogels, was evaluated.  
Gelatin hydrogels were successfully formed, and simultaneously sterilised, by electron 
irradiation at each of the experimental doses. 
Consistent with the findings of Douglas et al., (2012), who demonstrated that cPEG, collagen 
and OPF hydrogels could be successfully mineralised via the incorporation of ALP, and 
subsequent incubation in a solution containing glycerophosphate (GP) and Ca2+ (ALP 
substrates), successful mineralisation of the electron irradiated gelatin hydrogels exposed to 
this method was confirmed by numerous techniques. 
5.1 Dry Mass 
The statistically significant increase in dry mass percentage for each of the sample groups 
when the irradiation dose was elevated from 0 to 40kGy confirmed the relevance of this 
technique to crosslink gelatin hydrogels in the absence of toxic chemical crosslinkers, as 
previously discussed by Wisotzki et al (2014) and Wisotzki et al (2016). As expected, the 




when moving from 0 to 5kGy, and from 5 to 10kGy, after which the increase in dry mass 
began to plateau with subsequent increases in the irradiation dosage, presumably due to 
crosslinking nearing saturation point. This plateau was more severe in the sample groups 
containing 1.25 and 2.5mg/ml of ALP.  
Importantly, the ALP induced mineralisation of the 1.25 and 2.5mg/ml ALP hydrogels 
resulted in a dry mass percentage increase that overshadowed that attributable to the 
crosslinking effect of increasing the dose of electron irradiation. Thus, demonstrating the 
successful formation and incorporation of the mineral phase in the hydrogels.  
5.2 Raman Spectroscopy 
Raman spectroscopy provided direct evidence to reinforce the indirect indication of 
successful ALP induced mineralisation provided by dry mass analysis. Raman spectroscopy 
utilises vibrational, rotational, and other low frequency modes in a system to provide a 
structural fingerprint which enables the molecular structure and chemical composition of 
samples to be elucidated. 
Typically, the Raman spectra of bone is reported for a window from approximately 400cm-1 
to 1750cm-1 as this is the region which presents bands characteristic of both bone mineral 
and bone matrix (Mandair and Morris, 2015). The present study adhered to this norm in 
order to confirm successful ALP induced mineralisation of the gelatin hydrogels.  
The absence of bands representative of bone mineral observed in the control sample group 
(0mg/ml ALP in ddH20) was expected, due to the absence of exposure to the mineralisation 
process. Similarly, the low intensity bands representative of Amide III and CH2 deformation 
characteristic of the hydrogels gelatinous nature were expected. However, the peak of 
relatively low intensity, representative of phosphate, observed in the spectra of the 0mg/ml 




mineralisation procedure, this can most likely be explained by residual CaGP in the hydrogels 
due to incomplete washing out.  
The Raman spectra for both experimental groups (1.25 and 2.5mg/ml ALP in Ca-GP) changed 
dramatically. The presence of a phosphate band in Raman spectra representative of 
carbonated apatite’s is the most common mineral band used to confirm bone mineralisation. 
Therefore, this band was expected in the Raman spectra for both sample groups exposed to 
ALP. Instead, bands characteristic of the v1 stretching of PO43- were observed at 
approximately 957cm-1. As discussed by Mandair and Morris (2015), the exact position of the 
band characteristic of carbonated apatite’s (959cm-1) is susceptible to change due to the 
carbonate (CO32-) and monohydrogen phosphate (HPO42-) content of samples. A high HPO42- 
content, as possessed by newly deposited or immature bone mineral, is known to shift this 
band to a lower wavenumber, as observed in the present study (Crane et al., 2006; Kazanci 
et al., 2006). Thus, the presence of this band in both sample groups exposed to ALP 
(1.25mg/ml and 2.5mg/ml) provides further evidence for successful ALP induced CaP 
mineralisation of gelatin hydrogels. Similarly, as the intensity of this band approximately 
doubled when the ALP concentration of the hydrogels was increased from 1.25mg/ml to 
2.5mg/ml, ALP induced mineralisation is shown to be dose dependent.  
5.3 Fourier Transform-Infrared Spectroscopy (FT-IR) 
FT-IR spectra also evidenced successful ALP mediated mineralisation. Like the Raman 
spectra, in addition to both ALP supplemented hydrogels, bands representative of Phosphate 
were observed in the IR spectra for the 0mg/ml ALP Ca-GP control. This supports the theory, 
initially drawn from Raman spectroscopy, that residual Ca-GP remains in the hydrogels due 
to incomplete washing out. Additionally, bands indicative of Amide groups in the gelatin 
component of the hydrogel were pronounced in the 0mg/ml ALP ddH2O control and 




protein (gelatin) phase of the hydrogels accounted for a lower overall proportion of the 
sample mass, therefore indicating the presence of another (mineral) phase.  
Specifically, the band present at ~970cm-1 in the spectra for ALP supplemented samples may 
indicate that calcium deficient hydroxyapatite (CDHA) is present. This is common in aqueous 
solutions, where stoichiometric hydroxyapatite (HA; Ca:P = 1.67) does not generally form. 
However, CDHA containing composite hydrogels have demonstrated more efficient 
biodegradation and elevated cellular activity when compared with stoichiometric 
hydroxyapatite (Guo et al., 2009). 
The presence of CDHA is also suggested by the double bands in the region of 563-603cm-1 in 
spectra for sample groups. As the second band is less apparent, the spectra imply that the 
mineral formed is not highly crystalline and that amorphous CaP is also present. 
Alternatively, this may be explained by a decrease in the absorbance below ~600cm-1 which 
is caused by the apparatus itself. Specifically, the crystal used in attenuated total reflection 
(ATR) mode is known to absorb infrared radiation below this wavelength and decrease the 
intensity of the bands displayed in the spectra.  
The use of FT-IR in ATR mode may also be implicated in the difference in intensities observed 
between sample groups. Increased mineralisation is expected to be accompanied by similarly 
elevated intensity in FT-IR spectra. However, in the present study, both 0mg/ml ALP CaGP 
and 1.25mg/ml ALP sample groups presented intensities higher than those observed for the 
sample group supplemented with the highest concentration of mineralising enzyme. This 
may be explained by the need to ensure quality contact between the sample and the crystal 
in ATR mode, since the attenuation of the IR radiation that passes into the space 
immediately above the crystal during reflection is being measured. With increasing ALP 
concentration, hydrogels were noticeably ‘harder’. This made the process of pressing the 




contact. Although the preparation of samples is more laborious, further analysis should be 
conducted in transmission mode to circumvent issues with sample-crystal contact and auto-
absorbance under 600cm-1.  
5.4 Scanning Electron Microscopy (SEM) 
SEM was utilised to provide a visual representation of the effects of ALP induced 
mineralisation upon the surface topography of the gelatin hydrogels following 6 days of 
mineralisation in CaGP. As expected, the smooth surface observed for the ALP/CaGP-free 
control samples illustrated the absence of mineralisation in this group. Similarly, as the 
majority of the surface of the 0mg/ml ALP CaGP group was consistent with that of the ddH2O 
control, the sporadic deposits and ‘rougher’ sections which were observed support the 
previous suggestion that residual CaGP remains in the hydrogels and was not washed out 
completely, rather than providing evidence of mineralisation.  
The rougher surface morphology presented by both sample groups containing ALP 
(1.25mg/ml and 2.5mg/ml) provides visual confirmation of successful ALP induced 
mineralisation. Consistent with the findings of Douglas et al (2012), mineralisation appeared 
to manifest as homogenously distributed globular deposits with diameters like those induced 
by ALP in cPEG, collagen and peptide amphiphile gels (Douglas et al, 2012; Spoerke et al, 
2009). Despite this, further cross-sectional imaging of the hydrogels is necessary to enable 
the extent of successful mineralisation of the sub-surface regions to be evaluated.   
5.5 Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
ICP-OES was utilised to elucidate the elemental composition of the mineralisation product. 
This technique verified the presence of Calcium and Phosphorus in significantly increased 
quantities for both ALP containing hydrogels (1.25 and 2.5mg/ml) compared to ALP-free 




The Ca:P molar ratios of all the hydrogel groups, the highest of which was identified as 1.27 
(2.5mg/ml ALP), were found to be considerably lower than that of stoichiometric 
hydroxyapatite (1.67). This may be a result of the mineralisation medium (CaGP) possessing 
a Ca:P molar ratio of one, whereas media possessing greater molar ratios were used in 
studies reporting successful hydroxyapatite formation (Douglas et al, 2012; Spoerke et al, 
2009). Additionally, as discussed by Douglas et al (2012), varying concentrations of ALP and 
CaGP, as well as the type of hydrogel itself, may yield different mineral compositions. In this 
case, CDHA or a mixture of amorphous and crystalline calcium phosphate may be 
responsible for the reduced Ca:P molar ratio observed by ICP-OES; which supports the 
findings of FT-IR analysis. 
5.6 Compression Modulus 
The effect of ALP-induced mineralisation on the compressive modulus of each of the 
hydrogel groups was evaluated. Increases in the dosage of electron irradiation, as well as 
increases in ALP concentration, was hypothesised to result in an elevated compression 
modulus.  
For both ALP-free sample groups, although not statistically significant, the compression 
modulus increased with each increase in electron irradiation. This trend was not shared with 
the ALP containing hydrogels, where, despite a statistically significant increase in the 
compression modulus of samples exposed to 40kGy of electron irradiation compared to the 
0kGy control, increasing the dose from 10kGy to 15 or 20kGy resulted in a decreased 
compressive modulus.  
Hydrogels containing ALP (1.25mg/ml and 2.5mg/ml) demonstrated elevated compressive 
moduli, across the range of electron irradiation doses examined, compared to the 0mg/ml 
ALP hydrogels. Interestingly, however, while the compression moduli of samples at 2.5 




of electron irradiation, the compression moduli of hydrogels containing 1.25mg/ml were 
superior to those of the 2.5mg/ml group at the intermediate doses of electron irradiation. 
This suggests that, although mineralisation imparts increased mechanical properties onto the 
hydrogels, this is not proportional to the amount of mineral formed (represented by the dry 
mass percentage). Specifically, a statistically significant increase in dry mass percentage was 
displayed when ALP concentrations were raised from 1.25 mg/ml to 2.5 mg/ml, but this was 
not mirrored in the compression moduli. This suggests the absence of strong interactions 
between the mineral phases and polymeric phases of the mineralised gelatin hydrogels 
following ALP-induced mineralisation (Douglas, 2012). 
5.7 Cell Culture 
Irrespective of mineralisation or compressive strength, the ability of the gelatin hydrogels to 
support the adhesion and proliferation of cells is a crucial aspect which must be evaluated if 
this material is to have potential implications in bone tissue regenerative applications.  
As previously stated, gelatin itself is known to be biocompatible and has been proven to 
promote cellular growth (Wisotzki et al., 2016). In contrast to conventional methods used to 
crosslink gelatin which are known to elevate cytotoxicity and reduce cellular growth on 
gelatinous material gelatin hydrogels exposed to electron irradiation doses, exceeding those 
used in the current study (60kGy), had no significant impact on fibroblast cell death 
(Jayakrishnan and Jameela, 1996 and van Luyn et al., 1992). 
The present study evaluated the interaction of gelatin hydrogels, containing ALP and 
mineralised for 6 days, with a human osteosarcoma (MG-63) cell line.  Although successfully 
cultured MG-63 cells were visible on all of the sample groups after 24 hours, the cell 
coverage was most numerous in the gelatin control samples (0mg/ml ALP in ddH2O), with 
observable decreases seen when ddH2O was substituted with CaGP, and then further with 




consistent for both of the ALP-free sample groups at both of the subsequent time points 
visualised (4 and 7 days), cell coverage on samples containing ALP (1.25mg/ml and 
2.5mg/ml) appeared to decrease with each consecutive time point, with minimal coverage 
observed after 7 days.  
These observations were supported by the MTS assay – an indirect method to measure 
proliferation and cell viability by measuring the extent to which metabolically active cells 
have converted a soluble tetrazolium salt into insoluble formazan. The absorbance, and 
therefore metabolic activity, of samples containing ALP showed no significant increase from 
day 1 to day 7, with a significant reduction observed compared to both ALP-free samples at 4 
and 7 days.  
As stated by Wisotzki et al. (2016), even though no significant increase in fibroblast cell 
death was observed for electron irradiated gelatin hydrogels, cell viability and proliferation 
rates reduced slightly, in a dose dependent manner. This effect may have been present in 
the ALP-free gelatin hydrogels, however, as cell culture was only conducted on samples 
exposed to 40kGy of electron irradiation due to time constraints, additional testing with the 
remaining doses would have to be carried out to confirm this.  
Furthermore, it is unlikely that the reduction in cell coverage observed in the hydrogels 
which had been subject to ALP-induced mineralisation was a consequence of ALP mediated 
cytotoxicity. This method was utilised to mineralise a fibrin gel, in-vitro, which later 
enhanced bone tissue formation in-vivo (Osathanon et al.,2009). Therefore, it was 
hypothesised that these effects on cell growth could be attributed to an accumulation of 
Calcium which is released from the hydrogels – an issue which would be self-moderating in 
an in-vivo system. 
To examine this theory, a subsequent round of cell culture was carried out with ‘Thick’ (8mm 




samples would demonstrate elevated cell coverage compared to the ‘thick’ samples, as the 
concentration of calcium would be lower.  
Following 7 days of cell culture, fluorescent microscopy illustrated a seemingly confluent 
layer of cells on each of the ‘Thin’ sample groups, superior to that observed on the ‘Thick’ 
counterparts. Imaging of the ‘Thick’ samples returned results consistent with the first round 
of cell culture. Specifically, the gelatin control displayed good cell coverage, which was 
reduced considerably in samples containing 1.2 and 2.5mg/ml ALP.  
The MTS assay conducted for this round of cell culture, unlike the first round of cell culture, 
demonstrated an increase in absorbance, and thus cell metabolic activity, in all groups for 
day 7 compared to day 1. However, after 4 days, the MTS assay supported the observations 
made via fluorescent microscopy. All ‘Thin’ samples displayed elevated absorbance values 
compared to their ‘Thick’ counterparts, with a statistically significant increase demonstrated 
for the ‘Thin’ 2.5mg/ml ALP hydrogels compared to the ‘Thick’. However, contrary to the 
results observed for fluorescent microscopy, the metabolic activity observed from each 
sample group was increased in the ‘Thick’ hydrogels compared to their ‘thin’ counterparts. 
These discrepancies may be explained by several reasons. For example, the cells on the 
‘Thin’ hydrogels may have reached confluency and ceased to be metabolically active due to 
contact inhibition (Leontieva et al., 2014). Whereas the cells on the ‘Thick’ hydrogels 
continued to proliferate as they reached confluency at a later stage. Alternatively, as the 
layer of cells becomes more brittle when it reaches confluency, the cells could have been lost 
due to the manipulation of samples (pipetting and washing in particular) prior to the MTS 






5.8 Cell Culture Scanning Electron Microscopy 
Supplementary to fluorescent microscopy and the MTS assay, SEM of hydrogel samples fixed 
after 7 days of cell culture provided a more detailed insight into the morphology and 
attachment of the cultured cells. The confluent layers of cells visualised on the control 
hydrogels (0 mg/ml ALP in ddH2O) possessed clearly defined borders and visible filopodia, 
suggesting effective attachment. Similarly, large areas with complete cell coverage were 
observed in the remaining ALP-free samples. Again, filopodia could be seen, and attachment 
to the hydrogel surface appeared to be good.  
However, consistent with fluorescent microscopy and the MTS assay, the areas of the 
hydrogels with cell coverage became sporadic when ALP concentration was increased to 1.25 
and 2.5mg/ml. Layers of cells which appeared to have been confluent and subsequently 
peeled from the surface could be observed, while peeling cells and cells that appeared to 
have been lysed were also observed.  
Unfortunately, cell culture SEM was only carried out for the first round of cell culture. 
Therefore, as the results were observably different in the second round where both ‘Thick’ 
and ‘Thin’ samples were examined, SEM of these samples should be imaged to enable the 
morphology and attachment of the cultured cells to be evaluated. Similarly, one of the 
primary limitations of this study is the restriction of most of the analytical techniques to 
gelatin hydrogels exposed to one dose of electron irradiation (40kGy). Thus, the variation 
attributable to electron irradiation dosage is hard to compare. However, the results of the 
dry mass percentage, coupled with the compressive moduli analysis suggest that a lower 
dosage of electron irradiation may still be enough to produce the desired effects, in the 






Typically, the ability of hydrogels to satisfy requirements for use in bone tissue engineering is 
restricted by their generally weak mechanical properties and inability to mineralise with CaP 
in order to form durable interactions with bone tissue. Furthermore, the sterilisation of 
these materials is a common hurdle that must be overcome. 
In the present study, the previously elucidated method of ALP mediated mineralisation was 
coupled with electron irradiation to produce crosslinked gelatin hydrogel composites which 
circumvent these restrictions. Dry mass percentage, SEM, Raman, FT-IR and ICP-OES 
illustrated the successful formation of CaP (CDHA) in these hydrogels. As expected, this 
mineralisation coincided with an elevated compressive modulus, although this was not 
proportional to the amount of mineral formed. Importantly, preliminary in-vitro studies 
demonstrated that electron beam-crosslinked hydrogels, both mineralised and 
unmineralized, supported MG63 cell adhesion and proliferation of human osteoblast-like 
MG-63 cells.  
Ultimately, electron irradiation coupled with ALP mediated mineralisation demonstrates 
applicability to produce sterile hydrogels with properties compatible for use in bone tissue 
engineering applications. Specifically, with respect to the widely available in nature and 
inexpensive gelatin. However, further in-vitro and in-vivo studies are necessary to identify 







Chapter 3: Carbon Nanotube - Whey Protein Isolate Hydrogels 
7.0 Introduction 
7.1 Antibacterial Properties 
In addition to providing hydrogels with a mineralisation source, and the advantages which 
accompany this process, the incorporation of alternate nanoparticles may elicit additional 
advantages. Namely, enhanced mechanical reinforcement, antibacterial properties, and 
further promotion of bone-forming cell proliferation. 
Implant-related microbial infections, caused by bacteria and fungi, remain one of the 
primary causes of wound healing complications and, ultimately, failure of orthopaedic 
implants (Salomé Veiga and Schneider, 2013 and Romano et al., 2015). Specifically, the 
pathogenicity of infections with Escherichia coli, Pseudomonas aeruginosa, Staphylococcus 
aureus, Staphylococcus epidermis and species of Candida can lead to tissue morbidity or, in 
extreme cases, sepsis. Wound healing is compromised, and orthopaedic implants can fail 
because of pathogenicity at the tissue-implant interface (Salomé Veiga and Schneider, 2013). 
This is accompanied by increased socio-economic cost as the removal and subsequent 
replacement of the implants is necessary. The occurrence, and extent, of infections related 
to orthopaedic implants is a multifactorial issue. It is therefore necessary to consider: the 
surgical procedure itself, bacterial load, type of implant, microbial type, the host’s condition 
(immunocompromised etc) and the type of antibacterial prophylaxis prior to surgery 
(Romano et al., 2015).  
Complications of this nature have been significantly reduced in number due to current 
perioperative methods to prevent infection (such as antibacterial prophylaxis). Despite this, 
it has been reported that approximately 2.5% of primary hip and knee joint surgeries and 
10% of revision arthroplasties are still subject to complications induced by infections 




an underestimation of cases, which continue to rise. Importantly, pathogens that possess 
multi-resistance are also frequently isolated from complication sites (Aggarwal et al., 2014).  
Therefore, implantable biomaterials which possess antimicrobial activity, and thus, the 
ability to prevent/treat infections at implantation sites are desirable. Hydrogels can satisfy 
these criteria via various methods: antimicrobial agents can be directly encapsulated within 
or covalently immobilised onto the hydrogels, or the hydrogel itself can be obtained using 
materials that possess indigenous antimicrobial activity (Salomé Veiga and Schneider, 2013).  
Previous studies have utilised silver nanoparticles (NPs), which are known to possess 
antimicrobial properties against a wide range of bacteria and fungi, to increase the 
antibacterial properties of hydrogels (Salomé Veiga and Schneider, 2013). For example, 
Travan et al (2009) encapsulated NPs inside a hydrogel and subsequently demonstrated that 
this product displayed microbial activity towards Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus, Staphylococcus epidermis.  
7.2 Mechanical Properties 
Besides antimicrobial enhancement, mechanical reinforcement is the primary advantage 
bestowed upon hydrogels by the incorporation of particles. The mechanical integrity of 
orthopaedic tissue engineering scaffolds for implantation is a necessity. To avoid previously 
mentioned complications, such as stress shielding, re-fracture and implant related 
osteopenia, the mechanical properties of implants must also replicate those of the native 
tissue as closely as possible (Amini et al., 2012; Byrne et al., 2007). For hydrogels to 
successfully provide scaffolds for bone tissue engineering, their ordinarily weak mechanical 
properties must, therefore, be improved. As previously stated, mineralisation contributes to 
this increase in structural integrity. Similarly, as discussed by Nichol et al (2010), the type and 
extent of crosslinking, as well as the concentration of hydrogel precursors, can be 




However, these alterations may also detract from the original benefits that accompany 
hydrogels. For example, gaseous and nutrient exchange, which is necessary for the 
successful healing of bone tissue, may be restricted (Ulubayram et al., 2002). Therefore, 
numerous composites have been evaluated with the aim of increasing mechanical properties 
while maintaining their inherent advantages. The majority of these include: bioceramics such 
as hydroxyapatite and TCP, bioglasses and carbon nanotubes (Tozzi et al., 2002). 
7.3 Carbon Nanotubes 
Carbon nanotubes (CNTs) were first discovered by Iijima (1991), who observed a hollow 
tube-like structure, measuring only a few nanometres in diameter and up to a few 
millimetres in length, on the end of a graphite electrode. Since their discovery, CNTs have 
been the subject of a vast amount of research which has elucidated their unique structural, 
mechanical, electrical, electromechanical and chemical properties – each of which implicate 
CNTs in numerous applications.  
CNTs are allotropes of carbon. They are comprised of planar sheets of hexagonal bonded 
carbon forming honeycomb crystal lattices (graphene), rolled into cylindrical sheets. 
Depending on the number of graphene sheets folded to form these cylindrical structures, 
single walled CNTs (SWCNTs) or multi walled CNTS (MWCNTs) can be formed, each with 
unique properties. SWCNTs are cylindrical monolayers of graphene ranging in diameter from 
0.4 to 2nm, depending on the temperature during synthesis (Madani et al., 2013). Although 
they consist of one layer, the cylindrical honeycomb lattice structure of SWCNTs can be 
arranged in multiple ways, known as: armchair, zigzag and chiral arrangements. MWCNTs are 
comprised of multiple, cylindrical, graphene layers. Ordinarily, the central layer has a 
diameter of 1 to 3nm, while the outer cylindrical layer measures between 2 and 100nm in 
diameter. Like SWCNTs, MWCNTs can be arranged in multiple ways. The first is known as the 




involves the graphene sheet wrapping around itself to form a parchment-like structure 










Their ultra-light weight, high surface area and extreme durability implicate CNTs as ideal 
candidates for use in structural materials, specifically, nanocomposites. Polymers reinforced 
with CNTs have previously been exploited in numerous applications. For example, 
nanocomposites have been utilised in bicycles, boat hulls and golf clubs in the sporting 
industry (De Volder et al., 2013; Saito et al., 2014). Similarly, they have found applications in 
physics and electronics, where they have been used as components in supercapacitors, 
actuators, and displays such as television screens (De Volder et al., 2013; Saito et al., 2014). 
The electrical properties of CNTs have also allowed biomaterials containing them to be 
evaluated for nerve regeneration (Nunes et al, 2012) and muscle actuation (Baughman et 
al.,1999). They have also been proposed as drug delivery systems and implicated in the 
treatment of cancer (Lacerda et al, 2006). In terms of bone tissue engineering, they have 
been implicated in the production of hydrogels with enhanced mechanical properties, 
Figure 18: The structure of (A) Single walled carbon nanotubes (SWCNTs) and (B) 
Multi-walled carbon nanotubes (MWCNTs). 




without detracting from the flexible, porous structure which mimics that of the ECM (Tozzi et 
al., 2016). Usui et al (2008) demonstrated that, in a mouse model, MWCNTs were 
biocompatible, permitted bone repair and became integrated with bone tissue. Similarly, Seo 
et al (2014) found that the integration of 2% functionalised CNTs into chitosan/silica 
membranes increased both their tensile strength and elastic modulus considerably. This 
finding is supported by Yasmeen et al (2014) who observed an increase in compressive 
strength when chitosan gels were supplemented with CNTs. Additionally, with potential 
significance in their use as biomaterials in bone-tissue engineering, Zhao et al (2005) noted 
that CNTs promoted the formation of mineralised bone, while Yasmeen et al (2014) 
illustrated that the thermal properties of CNTs reduced the gelation time of chitosan gels 
from an hour to less than 10 minutes. 
Similarly, CNTs are known to possess antimicrobial activity against a broad spectrum of 
microorganisms. The first evidence of these properties was documented by Kang et al (2007) 
who observed antimicrobial activity of both SWNTs and MWNTs against Escherichia coli. 
Since this time, numerous studies have implicated CNTs in applications for the inactivation of 
pathogens (Liu et al., 2018). 
However, the use of CNTs in the biomedical field remains somewhat controversial. This is 
due to concerns regarding their toxicity, which has not yet been fully elucidated. Previous 
research into this topic has been inconsistent. However, it has also suggested that toxicity 
varies based upon method of exposure, shape, size, and composition (Madani et al, 2013).  
As discussed by Foldvari and Bagonluri (2008), studies have reported only mild inflammation 
when the route of exposure to CNTs is intravenous (IV) injection, oral, or dermal 
administration. However, severe inflammation has been reported as a result of inhalation. 
This may be due to their similar shape to asbestos particles – long, thin, lightweight crystals 




directed towards the respiratory system was demonstrated as a result of intratracheal 
instillation of CNTs, however, this was not confirmed by studies in which CNTs were inhaled 
directly, which showed no major damage to the respiratory system (Mitchell et al., 2007; 
Poland et al., 2008). 
Similarly, Takanashi et al (2012) evaluated the carcinogenicity of CNTs by injecting MWCNTs 
into the subcutaneous tissue of mice. Carbon black, a component used in black tattoo ink, 
was used as a comparison. The histological results demonstrated that injection with 
MWCNTs did not result in neoplasm formation and, in fact, carbon black implantation 
resulted in elevated carcinogenicity compared to MWCNTs. Additionally, inflammatory cells, 
such as lymphocytes and neutrophils were absent from the peripheral tissue following 
MWCNT injection. 
As discussed by Tonelli et al (2012), in terms of the direct effect of CNTs on bone tissue, most 
studies are conducted in-vitro. However, several in-vivo studies have been performed. 
Mostly, these studies examine MWCNTs in combination with polycarbosilane, chitosan, or 
hyaluronate, and have illustrated that bone tissue growth was improved without a notable 
immune response being initiated (Abarrategi et al., 2008; Mendes et al., 2010; Saito et al., 
2001; Usui et al., 2008; Wang et al., 2007). 
Contrastingly, multiple in-vivo studies have evaluated the effects of CNTs following dermal 
contact. For example, Murray et al (2009) examined the effects of non-purified CNTs on 
mouse skin. The generation of free radicals, oxidative stress, inflammation, and ultimately, 
dermal toxicity was observed because of this topical exposure. Purity of CNTs, therefore, has 
been implicated as a factor responsible for CNT toxicity, particularly via the dermal route. 
Impurities, generally, consist of metals. Cobalt (Co), Iron (Fe), Nickel (Ni), and Molybdenum 
(Mo) are used as a catalyst during the synthesis of CNTs (Donaldson et al., 2006). As a result, 




impurities following CNT synthesis. It has been elucidated that these metal residues can lead 
to cell death via mechanisms such as mitochondrial destruction and oxidative stress 
(Pichardo et al., 2012). Therefore, impurities are said to be a primary factor determining CNT 
toxicity. Purification of CNTs can be achieved via functionalisation (Sharifi et al., 2012).  
Ultrasonication is one method to accomplish functionalisation of CNTs as it stimulates the 
release of metallic impurities into solution. Toh et al (2012) demonstrated that CNT 
mediated toxicity was reduced significantly following ultrasonication for as little as 5 
minutes. Another common approach is to directly coat the CNTs with polyethylene glycol 
(PEG) – a biocompatible polymer which has demonstrated the ability to diminish CNT toxicity 
in-vivo (Bottini et al., 2011).  
 Importantly, the mechanisms by which hydrogels interact with incorporated particles are 
yet to be fully understood. Specifically, in-vitro studies are insufficient. Therefore, prior to 
their use in bone tissue engineering applications, the long-term activity of hydrogel 
composites, specifically in-vivo, should be elucidated. Cytotoxicity, biocompatibility, 
biodegradability and osteogenicity should all be established (Zhao et al. 2015). 
The present study aimed to evaluate the mechanical and antibacterial advantages imparted 
into WPI based hydrogels by the inclusion of CNTs. 
7.4 Whey Protein Isolate 
Whey protein isolate (WPI) is a protein derived from dairy sources and a by-product when 
producing foods such as Greek yoghurt. Recently, WPI, particularly in the form of hydrogels, 
has attracted attention for potential applications in bone tissue engineering.  
As the natural function of milk is to sustain the life of a new-born, it is an inherent source of 
components necessary for the development and regeneration of bone tissue. Milk proteins 
function as delivery mechanisms for essential micronutrients, such as calcium and 




and lactoferrin (Douglas et al., 2018). The primary groups present in milk are caseins, which 
account for 80% of proteins, and whey protein, which accounts for 20% of all proteins.  The 
primary components of whey protein are β-lactoglobulin (β-LG) and α-lactalbumin (α-LA), 
while lactoferrin, serum albumin and other proteins are present in reduced quantities (Do et 
al., 2016). In comparison with caseins, whey proteins possess a higher concentration of 
amino acids rich in sulphur. Proteins rich in sulphur are said to confer a higher protein 
efficiency ratio (weight gain to protein intake during a specified time period) and have 
important implications in immune modulation (Douglas et al., 2018). Furthermore, whey 
protein enhances protein synthesis in muscle cells, as they consist of branched chain amino 
acids (Walzem et al., 2002). The primary component of whey protein, β-LG, also possesses a 
calyx which provides it with the ability to bind to numerous ligands, including hydrophobic 
molecules (Kontopidis et al., 2004). This ability provides β-LG with functionality as a carrier 
protein to enhance both the uptake and solubility of hydrophobic molecules (Diarrassouba 
et al., 2015; Ha et al., 2013) 
With respect to bone tissue engineering, WPI hydrogels possess the advantage of 
simultaneous fabrication and sterilisation, as gelation is induced by heat.  Furthermore, a 
study conducted by Douglas et al (2018) concluded that WPI enhanced the growth of both 
human osteoblast-like Saos-2 cells, and human neonatal dermal fibroblasts. WPI also 
stimulated calcium deposition by Saos-2 cells and elevated the expression of type I collagen 
by fibroblasts. Finally, WPI induced the expression of markers characteristic of osteogenic 
cell differentiation by human adipose tissue derived stem cells (ASC), in a dose-dependent 
fashion, as well as increasing the activity of ALP. This, along with the availability and low cost 
of WPI, implicates it in bone tissue engineering applications. However, their applicability is 




This, therefore, underpins the decision to supplement WPI based hydrogels with CNTs to 
attempt to simultaneously increase their mechanical properties (Young’s modulus etc) and 
impart antibacterial activity – properties which are evaluated in the present study. 
 
8.0 Methods 
8.1 Whey Protein Isolate – Carbon Nanotube Hydrogel production 
Stock solutions of 40% w/v whey protein isolate were prepared by dissolving WPI powder in 
deionised H2O. A sonicator was used to facilitate dissolution and minimise foaming. 
Subsequently, 500µl of stock solution was added to Eppendorf tubes alongside the required 
amount of multi-walled Carbon Nanotubes (MWNTs; Sunnano Nanotech Ltd, China) to make 
0 (control), 2.5, 5, 10, 20 and 40% CNT samples. Once in Eppendorf tubes, samples were 
sonicated for an additional 30 minutes to aid dispersion of the CNTs.  
Next, samples were autoclaved at 134°C for 20 minutes, to simultaneously sterilise and 
induce gelation of the samples.  
8.2 Dry mass percentage 
Samples were weighed in the hydrated state, before being dried for 24 hours at 60°C. Dry 
mass percentage was then calculated using the following equation.  
 
Dry mass % = # !"#$%&	#(	)*+	,&-&"
!"#$%&	#(	%+)*-&")	,&-&"
$ x 100 
 
8.3 Laser Diffractometry 
Valerie Vanhoorne (Ghent University, Belgium) conducted laser diffractometry to measure 




0.2% Tween 80 and vortexed vigorously to suspend the powder. The suspension was then 
placed in an ultrasonic bath for 10 minutes, before being added to the measuring cell until 
the obscuration reached 10 to 30%. 5000 scans were taken, using a MS1 small volume 
dispersion unit, and a 300RF lens with a range of 0.05-800µm, stirred at 1500 rpm. 
8.4 Sample Preparation for Scanning Electron Microscopy 
Prior to SEM analysis, samples were mounted on aluminium stubs using carbon adhesive 
pads (both Agar Scientific Ltd, UK). Samples were then subject to sputter coating for 5 
minutes in an Edwards S150A sputter coater. Coating was carried out at 40mA, under 1.5 
bars of pressure. Samples were subsequently examined using a JEOL JSM-5600 instrument 
(JEOL Ltd, Japan), with a spot size of 14, and an acceleration voltage of 15. 
8.5 Cell Culture Sample preparation for Scanning Electron Microscopy 
Following cell culture, samples were also visualised by SEM to allow a more detailed 
evaluation of the surface topography of the hydrogels. Samples prepared as previously 
described in chapter 2, section 3.10. 
8.6 Fourier Transmission Infrared Spectroscopy (FT-IR) 
The molecular structure of the WPI-CNT hydrogels was examined using FT-IR, in 
collaboration with Aleksandra Benko (AGH University of Science and Technology, Poland). 
This was performed on a Bruker Tensor 27 spectrometer, in the middle infrared (MIR) region 
(4000-400cm-1). Samples were lyophilised to remove water residue, and ground to a fine 
powder using a mortar and pestle prior to analysis. The powder was subsequently mixed 
with approximately 200mg of KBr and pressed into pellets. Measurements were then taken, 
in transmission mode, by averaging 128 scans per sample, with a spectral resolution of 4cm-1. 
OPUS 7.2 software was utilised for data acquisition and editing. Manual baseline correction 
of all spectra was performed. In the case of WPI and its composites, deconvolution of the 




visualisation of changes in the number of bands and their relative intensities, caused by the 
presence of CNTs. Band positions were established based on the presence of maxima in the 
second derivative of the spectra, and fitting to the predetermined bell-type functions (mixed 
Gaussian/Lorentians) was performed until the value of the root mean square (RMS) of the 
fitted bands in relation to the starting spectra was lower than 0.0015. 
8.7 Cell culture 
To evaluate the ability of the WPI-CNT hydrogels to support bone cells, a human 
osteosarcoma (MG-63) cell line (Sigma-Aldrich, USA) was seeded on to the hydrogels.  
Hydrogels were cut into thin slices of approximately 2mm and placed into 48-well plates. At 
intervals of 1, 4 and 7 days, the adhesion, proliferation, and morphology of cells was 
assessed by fluorescent microscopy, while cell viability was evaluated via the MTS assay.  
Specifically, MG-63 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% foetal bovine serum (FBS; Nemecko, Germany), Penicillin and 
Streptomycin (50-100IU/ml and 50-100µg/ml, respectively), at 37°C, with 90% humidity and 
5% atmospheric pressure of CO2.  
8.7.1 Fluorescent Microscopy 
Hydrogels were cut into thin slices and placed into 48-well plates (Corning Incorporated, 
USA). Subsequently, 1ml of DMEM culture media containing 10,000 cells was added to each 
well (10,526 cells/cm2 growth area). Once the cells were seeded, the hydrogels were 
incubated at 37°C, with 90% humidity and 5% atmospheric pressure of CO2 once again.  
At the appropriate time point (1, 4 and 7 days) samples were washed with phosphate 
buffered saline (PBS), and subsequently fixed with 70% ethanol at -20°C for 10 minutes. 




Samples were stained with Hoechst and Texas red (both Sigma Aldrich, USA) diluted in PBS, 
at concentrations of 500ng/ml and 25ng/ml, respectively, for 15 minutes in dark conditions. 
Hoechst binds to the minor groove of double DNA with affinity for adenine and thymine rich 
sequences and is therefore used to stain the cell nucleus. The Hoechst stain is excited in the 
ultraviolet range (approximately 361nm) and emits blue fluorescence around 497nm. Texas 
Red is used to stain the cytoplasm, as it binds to reduced thiol groups which are present in 
cytoplasmic proteins. The maximal excitation is approximately 596nm, while the optimal 
emission is around 615nm (observed as red). 
After staining, samples were washed twice with PBS and subsequently visualised on an Axio 
ScTope.A1 microscope (Zeiss, Germany) using a digital camera and Zeiss software. 
8.7.2 Proliferation Assay (MTS) 
The MTS assay was used to assess the proliferation of MG-63 cells on each of the hydrogel 
sample groups at the appropriate time points (1, 4 and 7 days).  
DMEM, without phenol red, and supplemented with L-Glutamine and 10% FBS was used to 
dilute the MTS Cell Titer 96 Aqueous one solution cell proliferation assay kit (Promega, USA) 
by a factor of 1:6. For each sample group, 3 repeats and one sample without cells (to allow 
background to be subtracted) were included in the assay, along with a polystyrene plate 
control. First, samples were washed with PBS, transferred to a new well plate to remove 
interference from cells attached to the base of the polystyrene plate wells, and then 
incubated for 2 hours at 37°C, with 90% humidity and 5% atmospheric pressure of CO2, in 
0.5ml of the diluted MTS solution.  
After the 2-hour incubation, 100µl of the solution from each well was transferred, in 
triplicate, to a 96-well plate, to allow the extent of the yellow tetrazolium dye reduction to 
violet formazan to be quantified by a spectrophotometer, at a wavelength of 490nm (Tecan 




8.8 Cell Viability 
 
8.8.1 Human Foetal Osteoblast Cell Line Cell Preparation 
The ability of WPI-CNT hydrogels to support cell attachment and proliferation was also 
tested on a human foetal osteoblast cell line (hFOB; LGC Standards, USA), in collaboration 
with Doctor Susan A. Clarke at Queen’s University, Belfast. The hFOBs were cultured in 
DMEM/HAM F12 supplemented with 10% FBS, 50 mg/ml Geneticin + 2millimolar L-
glutamine. Cells were cultured at 34°C and 5% atmospheric pressure of CO₂. Hydrogels were 
placed into 24-well plates, before 50µl of cell solution containing 1000 cells was 
administered to the surface of each sample. Samples were then incubated for 30 minutes to 
allow cell attachment. Subsequently, 2ml of culture media was added to each well. Culture 
medium was replaced twice a week. 
8.8.2 Cell Proliferation & Differentiation 
To quantify the number of viable cells located on the base of the 24 well plates, a Crystal 
Violet assay was performed. Hydrogel samples were washed with PBS and transferred into a 
fresh 24 well plates for cell lysis. Cells that remained on the base of the well were fixed using 
4% paraformaldehyde (PFA). Crystal Violet dye was applied to each well before washing with 
distilled water 3 times and treating with 0.5% acidified methanol. Plates were read using a 
Tecan GENios multi-scan spectrophotometer at a wavelength between 550-620nm.   
8.8.3 Statistical Analysis   
 







8.9 Anti-bacterial – Colony Forming Unit Assay 
 
To identify potential antibacterial properties of WPI-CNT hydrogels, a CFU assay was 
conducted in collaboration with Doctor Raechelle D’Sa and Doctor Jenny Hanson at the 
University of Liverpool.  
The CFU assay enumerates the surviving bacterial cells following incubation with a 
surface/substrate. Bacterial cells were incubated with the WPI-CNT hydrogels, and after 24 
hours of contact time, an aliquot of solution was removed and plated on agar to determine 
the number of bacterial cells remaining in the solution.  
An overnight culture of S. aureus (1 x 10 8) in Luria broth (LB) was diluted to contain 1 x 10 6 
CFU/ml (in LB). 1 ml was then applied to each sample.  Samples were incubated at 37 ˚C with 
shaking at 180 rpm for 24 hours.  Subsequently, serial dilutions of the bacterial solutions were 
prepared in LB (up to 10-10), and 10 µl of each dilution was plated, in triplicate, on LB agar using 
the Miles and Misra method.  Following overnight incubation at 37˚C, colonies were counted, 
and statistical analysis performed using SigmaPlot.  Samples groups were 20% and 40% CNT-
WPI hydrogels, 0% control WPI hydrogel, and a blank (bacteria and broth without hydrogel).   
8.10 Mechanical Testing 
To evaluate the extent to which, if any, the addition of CNTs to WPI hydrogels increases their 
mechanical strength, mechanical testing was conducted in collaboration with Krzysztof 
Pietryga (AGH University of Science and Technology, Poland). Cylindrical samples, 8mm both 
in height and diameter were subject to compressive testing using a Zwick 1435 Universal 
Testing Machine. Test parameters were set at a speed of 10mm per minute, and a test range 




8.11 Statistical Analysis 
Statistical analysis was performed using the SPSS platform. One-way ANOVA coupled with 




Sample Abbreviation Description 
WPI Control 40% WPI - 0% CNT hydrogel 
2.5% CNT 40% WPI - 2.5% CNT hydrogel 
5% CNT 40% WPI - 5% CNT hydrogel 
10% CNT 40% WPI - 10% CNT hydrogel 
20% CNT 40% WPI - 20% CNT hydrogel 




9.1 Laser Diffractometry 
The size of the CNTs used to supplement WPI hydrogels in this study was elucidated via Laser 
Diffractometry, in collaboration with Valerie Vanhoorne (Ghent University, Belgium). 
Analysis illustrated that, on average over three runs, there were no CNTs below 1.95 µm in 
size and none above 48.27 µm (figure 19). However, only a negligible proportion of CNTs 
were demonstrated to be between 1.95 and 5.69 µm at the lower end, and between 30.53 
and 48.27 µm at the higher end of the CNT sizes analysed. 74.5% of the CNTs analysed 
displayed a size between 7.72 and 22.49µm, with the highest percentage (12.42%) between 































Figure 19: The average particle diameter of CNTs, analysed by Laser Diffractometry 




















9.2 Scanning Electron Microscopy (SEM) 
 
SEM was utilised to analyse differences in the surface topography of WPI hydrogels 
supplemented with CNTs at concentrations at 0, 2.5, 5, 10, 20 and 40% (figure 20). 
Specifically, this technique was used to allow the evaluation of CNT dispersion and 
homogeneity within the hydrogels, in addition to their effects on sample integrity.  
The WPI control (0% CNT) samples displayed a homogenous, smooth, surface topography 
(Figure 20A). As hypothesised, the surface became increasingly rough as the CNT 
concentration was increased. From the lowest concentration, 2.5% CNTs (Figure 20B), CNTs 
could be observed, encapsulated within the WPI hydrogels and penetrating through the 
exterior, coated in protein. The frequency of these observations and the roughness of the 
samples increased with increasing CNT concentration.  
At the highest CNT concentrations (20 and 40%), the surface of the hydrogel samples 
displayed an exceedingly porous topography, with seemingly reduced homogeneity. CNTs 
which were attached to the hydrogels, but not fully encapsulated in the protein, could also 































Figure 20: SEM images of WPI hydrogels containing varying CNT concentrations. 0% 







9.3 Fourier Transmission Infrared Spectroscopy (FT-IR) 
FT-IR spectra of CNT samples displayed a wide, symmetric band at approximately 3443 cm-1, 
which is representative of the presence of hydroxyl groups. A cluster of bands was also 
present in the region of 1750 and 1000 cm-1 which are generally attributed to bonds 
between Carbon and Oxygen or Hydrogen (C=O, C-O and C-H). The complex band between 
3000 and 2800 cm-1 also suggests the presence of bonds between Carbon and Hydrogen, as 
this is representative of CH2 and CH3 groups. 
Spectra for the WPI and WPI-CNT hydrogels, as expected, illustrated features typical of 
proteins. A wide, complex band representative of the presence of a carboxyl group was 
observed between 3800 and 2300 cm-1. Within this band, numerous shoulders were 
observed that may be attributed to a variety of interactions, including C-O, hydroxyl, amide A 
and B and =C-H in alkenes (Garidel and Schott, 2006). In the region below 1800 cm-1, bands 
characteristic of amide I, amide II and amide III with different wavelengths attributed to 
vibrations of multiple functional groups were observed (Barth, 2007). It was also 
documented that the shape and relative intensities of bands observed on WPI spectra were 
impacted, in a dose dependent manner, by increasing CNT concentration.  This is clearest to 
see in the altered shape of the complex band between 3800 and 2300 cm-1 and the 




























Figure 21: FTIR spectra of WPI-CNT hydrogel samples, presented in the region between 
4000-400 cm-1. The spectra are offset and maximized for better clarity. Regions of most 




9.4 Cell Culture 
9.4.1 Fluorescent Microscopy 
The interaction of WPI-CNT hydrogels with a human osteoblast-like (MG-63) cell line was 
evaluated at intervals of 1, 4 and 7 days. The adhesion, proliferation, and morphology of cells 
present on the samples was assessed by fluorescent microscopy, as illustrated in figure 22. 
Cell nuclei were successfully stained (blue) with Hoechst, while the cytoplasmic regions of 
cells were successfully stained (red) with Texas Red. 
Following the first 24 hours of cell culture, fluorescent microscopy (figure 22) illustrated that 
MG-63 cells were present on all WPI hydrogels (0, 5, 10, 20 and 40% CNTs). The WPI control 
(0% CNT), 5% and 10% CNT samples all displayed good cell coverage across the hydrogel 
samples. Observed cells also presented a seemingly healthy morphology. However, samples 
with elevated CNT concentrations (20 and 40%) exhibited reduced cell coverage and less 
defined cytoplasmic regions.   
On the 4th day of cell culture, the cell coverage on both the WPI control and 5% CNT samples 
appeared to be reduced, with regions of little to no cell coverage identified. Despite this, 
clusters of MG-63 cells were still identified with clearly defined cytoplasmic regions and well 
spread morphologies on both samples.  The cell coverage on the remaining sample groups 
(10, 20 and 40% CNT) appeared to increase in comparison to the observations following the 
first 24 hours. Again, the 10 and 20% CNT samples displayed seemingly healthy 
morphologies, while the 40% sample group remained somewhat less defined. 
Following the 7th day of cell culture, good cell coverage was identified via fluorescent 
microscopy for sample groups containing 0 to 20% CNT. Again, the nuclei and cytoplasmic 
regions of observed MG-63 cells were well defined. However, as with the previous time 
points, the presence of MG-63 cells with seemingly healthy morphologies appeared reduced 


































Figure 22:  Fluorescent microscopy of MG-63 osteoblast-like cells cultured on WPI 
hydrogels supplemented with CNTs at concentrations of 0, 5, 10, 20 and 40% at 1, 4 and 
7 days. Cells stained by Hoechst (nuclei, blue) and Texas Red (cell cytoplasm, red). Scale 




9.4.2 Proliferation (MTS) Assay 
The previously discussed MTS assay, which measures the extent to which metabolically 
active cells convert a soluble tetrazolium salt into insoluble formazan; thus, indirectly 
indicating proliferation, cell viability and cytotoxicity of samples, was repeated following 
WPI-CNT cell culture (Figure 23) 
After 24 hours, no statistically significant reduction (P<0.05) in metabolic activity from the 
cultured MG-63 cells was observed for cells cultured on the WPI control (0%) or 5% CNT 
samples compared to the polystyrene control, although the absorbance recorded for the 
polystyrene control was more than double that of the WPI control. The absorbance values 
recorded for the 10 and 20% CNT samples, although significantly reduced compared to the 
polystyrene control, demonstrated no statistically significant reduction when compared to 
the remaining sample groups.  
After 4 and 7 days of cell culture, the absorbance values recorded for all sample groups, 
including the WPI control, displayed a statistically significant reduction in intensity compared 
to the polystyrene control at the corresponding time point. Despite this, after 4 days of cell 
culture, there was no statistically significant difference between the absorbance values for 
the 10 or 20% CNT samples, compared with that of the WPI control. Interestingly, the 5% 
CNT samples showed a statistically significant increase of 0.23 a.u compared to the WPI 
control.  
Following 7 days of cell culture, the absorbance value recorded for the WPI control 
(0.604a.u.) were significantly (P<0.05) elevated compared to the remaining sample groups. 
The lowest absorbance value within CNT supplemented hydrogels was from the 20% CNT 
group (0.247) and the highest for 10% CNT samples (0.449). Despite this, it is important to 
note that all sample groups displayed a statistically significant increase in absorbance after 7 






























































Day 1 Day 4 Day 7
Figure 23: Proliferation of MG-63 osteoblast-like cells on 40% WPI hydrogels with CNT 
concentrations 0 (WPI control), 5, 10 and 20%, assessed at 1, 4 and 7 days, via the MTS 
assay. As per method, Hydrogels were placed in 500µl of MTS solution and incubated for 
2 hours. Absorbance was then measured via a spectrophotometer (at 490nm). 
Polystyrene control also included. * indicates statistical significance compared to the 
polystyrene control at the corresponding time point (P<0.05). # indicates statistical 













9.5 Cell Culture Scanning Electron Microscopy 
To supplement the previously described methods to evaluate the ability of WPI-CNT 
hydrogels to support the growth of MG-63 cells, SEM was utilised to provide enhanced detail 
into the extent of attachment and the topography of cultured cells on the surface of 
hydrogel samples (figure 24).  
Consistent with the previous analysis, SEM analysis of 5% CNT-WPI hydrogels presented 
large areas of cell coverage on the hydrogel surface. Cells appeared well spread with clearly 
defined boarders, and visible filopodia, suggesting successful attachment. However, rounded 
cells were also visible in places (figure 24A). Additionally, CNTs were visibly integrated into 
the MG-63 cell layers and could be observed within them, as well as protruding from them.  
Similarly, when 10% CNT-WPI hydrogels were imaged following 7 days of cell culture (figure 
24C and D), large layers of cell coverage were observed, with a spread morphology and 
filopodia once again visible on the hydrogel surface. Despite this, the visible layers of MG-63 
cells appeared to present areas with cells debris and gaps within them on a more frequent 
basis than the 5% CNT samples (D). When imaged at higher magnification, the boarders of 
cells could be seen detaching from one-another and peeling away from the layer (D). 
As the CNT concentration was elevated, first to 20% (figure 24E and F) and then to 40% 
(figure 24G and H), the areas of hydrogel presenting MG-63 cell coverage was visibly 
reduced. On both 20% and 40% CNT samples, imaging revealed layers of cells which may 
previously have been confluent. Cells with a spread morphology remained visible, however, 
these were somewhat sporadic and vastly outnumbered by cells presenting unhealthy 
morphologies. The frequency of observable cell debris from cells which appear to have been 

























Figure 24: SEM images of WPI hydrogels containing CNT concentrations of 5% CNT (A 
and B), 10% CNT (C and D), 20% CNT (E and F) and 40% CNT (G and H) after the 7th day 








9.6 Cell viability  
The Crystal Violet assay is often utilised as an indirect measurement of cell death. When 
adherent cells die, they detach from the surface and are therefore not stained with Crystal 
Violet, whereas live cells remain adhered to the surface and are subject to staining. 
Therefore, the higher the absorbance observed when read with a spectrophotometer, the 
greater the presumed biomass.  
When hFOB cells cultured in wells containing WPI hydrogels supplemented with CNTs were 
subjected to this assay, each of the experimental groups (0%, 20% and 40% CNT) displayed 
an absorbance below that of the polystyrene control after 24 hours. The observed 
absorbance values were elevated for both 20 and 40% CNT hydrogels compared to the WPI 
control. However, the only statistically significant difference (P<0.05) after 24 hours was 
between the WPI and Polystyrene control. On the fourth day, the absorbance values reduced 
for all sample groups. Statistically significant differences were observed between both CNT 
supplemented hydrogels compared to the polystyrene control, but not the WPI control. 
Although the absorbance values increased to beyond those observed on day four after seven 
days in all sample groups, the only statistically significant elevation was in the WPI control. 





























Figure 25: A Crystal Violet assay of the well in which hydrogel cell culture samples had 
been removed. As per method. hFOB cells that remained on the base of the well were fixed 
using 4% paraformaldehyde (PFA). Crystal Violet dye was applied to each well, washed with 
distilled water 3 times and treated with 0.5% acidified methanol. Plates were read using a 
Tecan GENios multi-scan spectrophotometer at 595nm. Wells that contained 0 (WPI 
Control), 20 and 40% CNT samples were evaluated alongside a polystyrene (PS) control. 
Error bars show standard deviation. * indicates a statistically significant difference 
compared to the PS control at the corresponding time point (P<0.05). # indicates a 

















































9.7 Antibacterial Testing – Colony Forming Unit Assay  
The potential antibacterial properties of the WPI-CNT hydrogels were evaluated in 
conjunction with Doctor Raechelle D’Sa and Doctor Jenny Hanson at the University of 
Liverpool. This was conducted via three runs of a CFU assay, each time in triplicate.  
9.7.1 Experiment One 
Following 24 hours of incubation with each sample group, serial dilutions of the bacterial 
solutions and subsequent analysis of agar plates following overnight incubation at 37 ˚C, it 
was observed that the presence of CNTs reduced the number of bacterial colonies formed.  
The control WPI hydrogels (0% CNT) displayed no antibacterial activity, in fact, a statistically 
significant increase (P<0.05) in the number of bacterial colonies was observed compared to 
the blank control (no hydrogel added during incubation). However, the 20% CNT hydrogels 
reduced the number of colonies observed, in a statistically significant manner, by 76%, 
compared to the WPI control group. This reduction was elevated to 86.7% when CNT 
concentration was increased to 40%, as illustrated in figure 26A.  
Additionally, both the 20% and 40% CNT sample groups reduced the number of colonies 
observed compared to the blank control (45.4 and 69.6%, respectively), however, this was 
not deemed statistically significant (P<0.05) by a one-way ANOVA.  
9.7.2 Experiment Two 
Contrastingly, experiment two demonstrated no statistically significant difference (P<0.05) in 
the number of colonies present between the 20% CNT, WPI or blank control sample groups. 
Despite this, the 40% CNT displayed a statistically significant reduction of approximately 72% 




9.7.3 Experiment Three 
In the final experiment performed, the blank control group displayed confluent bacterial 
growth, meaning colonies were too dense for statistical analysis to be performed – 
therefore, the blank control was excluded from figure 26C.  
Consistent with experiment one, the addition of CNTs to the WPI hydrogels reduced the 
number of colonies observed following bacterial incubation, compared to the WPI control. 
The addition of 20% CNTs resulted in a statistically significant reduction of 38%, which was 
elevated to 49.3% when the CNT concentration was increased to 40%.  
Overall, the supplementation of WPI hydrogels with CNTs appears to provide them with 



























































































# All * 
# All * 
# All 
Figure 26: 3 runs of a Colony forming Unit Assay illustrating the number of surviving 
bacterial cells following 24 hours of incubation with WPI hydrogels supplemented with 
0%, 20% and 40% CNTs. ‘Blank’ control also shown in experiment 1 and 2 (A and B).  * 
indicates statistical significance (P<0.05) compared to the blank control. # indicates 
statistical significance between hydrogel  groups. Broth missing from run 3 as statistical 







9.8 Mechanical Testing 
The effects of adding CNT to WPI hydrogels on the hydrogels mechanical properties were 
evaluated using a Zwick 1435 Universal Testing Machine – these studies focused on the 
higher CNT concentrations, namely, 20 and 40% as shown in figure 27. 
9.8.1 Compressive Strength 
Addition of CNTs to WPI hydrogels resulted in a decrease in compressive strength (figure 
27A). The control WPI samples (0% CNTs) demonstrated a mean compressive strength of 
4.11Mpa which reduced by approximately 50%, in a statistically significant manner, as a 
result of CNT supplementation (both 20 and 40%). Although not statistically significant, the 
compressive strength of the 40% CNT sample group demonstrated a mean increase of 
0.17MPa compared to the 20% sample group (1.84 to 2.01MPa).  
9.8.2 Young’s Modulus 
Supplementing WPI hydrogels with CNTs (both 20 and 40%) increased the Young’s Modulus 
of samples in a dose-dependent manner compared to the WPI controls (figure 27B). 
Specifically, the addition of 20% CNTs increased the Young’s Modulus from approximately 
2.57MPa (WPI control) to 3.28MPa. This was elevated further to approximately 4.39MPa 
when the CNT concentration was increased to 40%. Both increases were deemed to be 
statistically significant compared to the WPI control (P<0.05). 
9.8.3 Strain at Break 
Finally, the addition of CNTs resulted in a decrease in the strain at break of the hydrogel 
samples (figure 27C). WPI control samples deformed by a mean 5.69mm (71.14%) before 
breaking. The mean strain at break decreased to 44.67% in the 20% CNT experimental group, 
and further to approximately 28.13% in the WPI hydrogels supplemented with 40% CNTs. 
Statistical significance was confirmed compared to the WPI control and between 20 and 40% 



























Figure 27: Mechanical testing of cylindrical WPI hydrogels containing 0, 20 and 40% 
CNT, with a Zwick 1435 Universal Testing Machine. A) Compressive strength, B) Young’s 
Modulus, C) Strain at break. * indicates statistical significance compared to the WPI 
control (P<0.05). # indicates statistical significance between WPI-CNT groups (P<0.05). 



































































9.9 Dry Mass  
The dry mass percentages of WPI hydrogels (the mass of the hydrogel not attributable to 
water) containing CNTs at quantities of 0 to 40% are illustrated in figure 28.  
The addition of lower concentrations of CNTs (2.5, 5, and 10%) to the hydrogels appeared to 
have no effect on the dry mass percentage, compared to the control WPI hydrogels (0% 
CNT). The mean dry mass percentage for each of these 4 groups was approximately 33%. An 
increase to 44% was observed when CNT concentration was increased to 20%, however, this 
was not deemed to be significant. Compared to the control, the mean dry mass percentage 
approximately doubled for the 40% CNT samples (65%). This value, as demonstrated by 






















































Figure 28: Dry Mass percentages of 40% WPI hydrogels with CNT concentrations of 0, 
2.5, 5, 10, 20 and 40%. Samples were weighed in the hydrated state, dried for 24 hours 
at 60°C, and weighed again for the dry mass % to be calculated. Error bars display 
standard deviation. Differences considered significant if p < 0.05. ‘*’ relates to the 
significant difference compared to the WPI control (* P<0.05). ‘All’ relates to the 





As previously discussed, research has elucidated unique properties which implicate CNTs in 
numerous applications. Specific to bone tissue engineering, hydrogels supplemented with 
CNTs have demonstrated enhanced mechanical properties (Tozzi et al., 2016 and Usui et al., 
2008) and reduced gelation time as a result of the thermal properties demonstrated by CNTs 
(Yasmeen et al., 2014). Furthermore, CNTs have been shown to promote the formation of 
mineralised bone (Zhao et al., 2005). However, the antimicrobial activity which they have 
demonstrated against a range of pathogens is the primary reason for their selection in the 
present study.  
Similarly, WPI is a ‘green’ material with low production costs and multiple potential 
advantages in the bone tissue engineering space. As gelation is induced by heat, hydrogels 
comprised of WPI possess the benefit of simultaneous fabrication and sterilisation. 
Furthermore, WPI has been shown to enhance the growth of both human osteoblast-like 
Saos-2 cells and human neonatal dermal fibroblasts (FIB), in addition to inducing the 
expression of markers characteristic of osteogenic cell differentiation by human adipose 
tissue derived stem cells (ASC). This, along with the availability and low cost of WPI, 
implicates it in bone tissue engineering applications and underpins the decision to evaluate 
WPI based hydrogels in the present study. 
Therefore, the purpose of the current study was to supplement WPI hydrogels with CNTs, 
with the intention of conveying the advantages of their unique properties onto the 
hydrogels. Subsequently, the efficacy of WPI-CNT hydrogels as materials with potential 
implications in bone tissue engineering was evaluated. Areas of specific interest were the 
potential mechanical reinforcement and antibacterial properties induced by CNT 




Firstly, the laser diffractometry measurements indicated that there were no CNTs below 
1.95µm, with only a negligible proportion between 1.95µm and 5.69µm. As CNTs are known 
to measure only a few nanometres in diameter, these results may represent agglomerates, 
rather than individual CNTs. CNTs tend to agglomerate due to strong van der Waals forces, 
meaning that surfactants or ultrasonication are required to aid their dispersion in solution 
(Krause et al, 2010). An alternative technique, such as Transmission Electron Microscopy 
(TEM), may be more appropriate to evaluate the size of the CNTs used in this study.   
As expected, increasing the CNT concentration of WPI hydrogels resulted in considerably 
rougher microstructures. When WPI-CNT composites were examined by SEM, CNTs were 
visible both encapsulated within the hydrogels and penetrating through the exterior coated 
in protein. At the highest CNT concentrations examined (20 and 40%), homogeneity of the 
hydrogels was notably reduced. Areas of exceedingly increased porosity were visible, as 
were CNTs attached to the hydrogels but not coated in protein.  
Subsequent imaging of cross-sectional samples of WPI-CNT hydrogels should be conducted 
for the homogeneity of CNT dispersion to be evaluated more accurately. This will also 
confirm the efficacy of the vortexing, and sonication steps carried out prior to gelation, 
which, as discussed by Foldvari and Bagonluri (2008), is one of the easiest methods to 
achieve dispersion of CNTs. However, it is also important to note that the concentrations of 
CNTs used (20% and 40%) are particularly high in this study as the intention was to maximise 
biological and mechanical effects as a result of CNT supplementation. For example, previous 
studies, such as that by Seo et al (2014), evaluated composites supplemented with only 2% 
functionalised CNTs. 
10.1 Fourier-Transform Infrared Spectroscopy (FT-IR) 
Further to visual analysis, FT-IR analysis evaluated the interaction between the CNTs and WPI 




between CNTs and the protein phase of the hydrogels was confirmed by this technique. 
Functional groups of CNTs were found to chemically interact with functional groups of the 
WPI, break intermolecular bonds between peptide chains and, ultimately, force the 
transition from Beta pleated sheets to alpha helices. Importantly, as the effect on the shape 
and intensity of the spectra was exaggerated at higher doses, it is suggested that this 
interaction occurs in a dose-dependent manner. 
10.2 Mechanical testing 
As previously stated, one of the primary motives for the inclusion of CNTs in WPI hydrogels 
was the hypothesised mechanical reinforcement that would accompany it. This theory was 
investigated in conjunction with AGH University of Science and Technology.  
Consistent with the suggestion of a dose-dependent interaction between CNTs and the WPI 
hydrogel, the Young’s moduli of these composites elevated with the inclusion of CNTs, in a 
similarly dose-dependent manner. However, a decrease in both compressive strength and 
strain at break was observed in CNT supplemented hydrogels compared to the control.  
Therefore, CNT addition to WPI hydrogels was demonstrated to result in stiffer, but not 
compressively stronger, hydrogels. This is inconsistent with studies such as that by Seo et al 
(2014) who observed an increase in compressive strength of chitosan hydrogels 
supplemented by CNTs, and Tozzi et al (2016) and Usui et al (2008) who demonstrated 
considerable increases in the tensile strength and elastic moduli of chitosan and silica 
membranes augmented with CNTs. However, lower concentrations of CNTs were used in 
these studies. Consistent with FT-IR analysis, this suggests that the presence of CNTs in 
higher quantities interferes with the proteinaceous interactions of the WPI hydrogels, 
ultimately having a negative impact on hydrogel integrity.  Therefore, in line with the CNT 
concentrations used in previous studies, subsequent mechanical testing should be 




compressive strength of WPI hydrogels. However, irrespective of the in-vitro decrease in 
mechanical strength observed in this study, CNT supplemented hydrogels may increase the 
mechanical strength in-vivo. Specifically, as observed by Usui et al (2008) in a mouse model, 
the CNTs would remain and be able to integrate with the bone tissue after the hydrogel is 
naturally broken down.  
10.3 Antibacterial 
The remaining primary motive for the inclusion of CNTs in WPI hydrogels, hypothesised CNT 
induced antibacterial properties, was confirmed by way of the colony forming unit assay.  
As the bacterial colonies observed following incubation with WPI hydrogels were more 
numerous than those observed in the blank control (no hydrogel present during incubation), 
the present study suggests that WPI hydrogels provide an environment which may 
encourage the growth of Staphylococcus aureus, in the absence of CNTs. This may not be 
surprising, as milk proteins are known to function as delivery mechanisms for essential 
micronutrients (Douglas et al., 2018). 
However, the successful dose-dependent reduction in the number of Staphylococcus aureus 
colonies which accompanied the supplementation of WPI hydrogels with CNTs confirms the 
hypothesis. Therefore, the current study suggests that the supplementation of WPI 
hydrogels with CNTs does impart antibacterial activity, at least in the case of Staphylococcus 
aureus.  
As previously discussed, implant related microbial infections caused by bacteria and fungi, 
such as Staphylococcus aureus, are one of the primary causes of wound healing 
complications and failure of orthopaedic implants (Romanò et al., 2015; Salomé Veiga and 
Schneider, 2013). Both the incidence and socio-economic cost of these complications 
continue to rise (Aggarwal et al., 2014; Romanò et al., 2015). Therefore, the apparent 




applications and, therefore, may implicate them in bone tissue regeneration. However, as 
the size and type of CNT (SWNT or MWNT) is known to influence the potency of their 
antibacterial effect in isolation (Kang et al., 2008), this should be examined in composites 
(such as those in the present study) in future research. 
10.4 Cell Culture 
However, the mechanism by which CNT conveys antibacterial properties must not elicit 
cytotoxic effects, should they be used in these applications. Therefore, the ability of a human 
osteosarcoma (MG-63) cell line to adhere and proliferate on WPI-CNT hydrogels was an 
important aspect of the present study.  
Although cells were present on all sample groups following 4 hours of cell culture, good cell 
coverage was observed on hydrogels with 0, 5 and 10% CNT, with reduced cell coverage 
exhibited for hydrogels with elevated CNT concentrations. On the 4th day of cell culture, cells 
on both the WPI control and the 5% CNT hydrogel had been visibly removed due to 
mechanical interference when manipulating samples. This could be because samples had 
reached confluency and had become more susceptible to damage of this nature. Following 
the 7th day of cell culture, seemingly good cell coverage was observed on samples ranging 
from 0 to 20% CNT, with visibly fewer cells on the 40% hydrogels. However, the reduction in 
cells on the 40% CNT samples suggests that higher concentrations of CNTs have a negative 
impact on the viability of MG-63 cells.  
It is important to note that 40% CNT hydrogels were not subject to the MTS assay because 
the samples had become exceedingly ‘powdery’ and could not withstand the manipulation 
necessary to complete the assay. Once again, this supports the suggestion that the presence 
of CNTs in higher quantities interferes with the proteinaceous interactions of the WPI 




the reduction in cell number observed on 40% samples after cell culture, as stiffer surfaces 
are known to promote the differentiation of cells. 
Despite this, following the 7th day of cell culture, even though CNT supplemented hydrogels 
all demonstrated a significantly lower absorbance than that of the control, the absorbance 
for each sample group was elevated in a statistically significant manner compared to that 
observed after 24 hours. This supports the findings from fluorescent microscopy and 
suggests that cells remained both viable and metabolically active after 7 days exposure to 
CNT supplemented hydrogels, even at concentrations of 20%. However, it should not go 
unnoticed that the 40% CNT samples displayed considerably reduced cell coverage when 
subject to fluorescent microscopy. It can, therefore, only be assumed that this reduction 
would also be seen in the MTS assay.  
It should also be noted that, although cell culture-based toxicity assays are popular methods 
for investigating the toxicity of nanotubes (Wang et al., 2012), the results are often 
inconsistent between research groups. This may be due to the interaction of the CNTS with 
the dyes used in the cytotoxicity assays, ultimately altering the colour emitted and resulting 
in false readings (Liu et al., 2009). However, it would be expected that these effects would be 
greatest at the highest concentrations, whereas in the current study, the absorbance was 
lowest for the samples with the highest CNT concentration.  
10.5 Cell culture Scanning Electron Microscopy 
SEM enabled the morphology of MG-63 cells cultured on the WPI-CNT hydrogels to be 
examined in greater detail. Due to time constraints, this method was only utilised to image 5 
to 40% CNT hydrogels. 
Although large areas of cell coverage could be observed, particularly on the 5% CNT 




cells to be imaged. Importantly, even at 5%, CNTs were visibly integrated into the MG-63 
cells, observed both within and protruding from them. 
With increasing CNT concentration, cells could be seen detaching from the surface, coverage 
reduced and cell debris from cells which appear to have been lysed increased in frequency. 
Thus, suggesting that CNT supplemented hydrogels have cytotoxic effects on MG-63 cells. 
As previously stated, it has been suggested that CNT mediated toxicity varies based upon 
several factors, including method of exposure, shape, size, and composition (Madani et al., 
2013). Specific to the effects of CNTs on bone tissue, multiple in-vivo studies combining 
MWCNTs in combination with chitosan or hyaluronate (rather than WPI) have indicated 
enhanced bone tissue growth in the absence of a notable immune response (Abarrategi et 
al., 2008; Mendes et al., 2010; Saito et al., 2001; Usui et al., 2008; Wang et al., 2007). 
An important factor to consider is the purity of MWCNTs. Metals such as Cobalt (Co), Iron 
(Fe), Nickel (Ni), and Molybdenum (Mo) are used as a catalyst during CNT synthesis 
(Donaldson et al., 2006). Residues of these metals can become encapsulated within the 
graphene layers and remain as impurities, which have been implicated to induce cell death 
via mechanisms such as mitochondrial destruction and oxidative stress (Pichardo et al., 
2012). 
Methods of purification have been shown to reduce CNT mediated toxicity significantly. As 
Toh et al (2012) demonstrated with CNTs exposed to ultrasonication for as few as 5 minutes. 
In the current study, CNTs were sonicated once in the WPI solution to aid dispersion. 
However, a proposed alteration to the experimental technique would be to sonicate the 
CNTs individually, before adding them to the solution. 
Furthermore, as 2.5% CNT samples were absent from some of the primary tests due to time 
constraints, these should be repeated with the lower concentrations of CNTs. Overall, the 




However, additional research into WPI-CNT hydrogels, and CNTs alone must be conducted 
for their toxicity to be fully understood and their potential in biomedical applications to be 
realised. Furthermore, the ability to simultaneously fabricate and sterilise relatively low cost 
‘green’ WPI hydrogels provides an interesting platform for further research. For example, 
WPI hydrogels could be supplemented with alternative antimicrobials, or exposed to ALP-
induced mineralisation to optimise their properties for potential use in bone tissue 
regenerative applications.  
11.0 Conclusion 
The present study demonstrated that the incorporation of CNTs successfully increased the 
Young’s modulus, demonstrated satisfactory cytocompatibility towards MG63 cells and 
provided WPI hydrogels with antibacterial activity against Staphylococcus aureus. Therefore, 












Chapter 4: Phloroglucinol-WPI Hydrogels 
12.0 Introduction 
Phenolic compounds, subunits of polyphenols, have also been implicated as components of 
an antimicrobial hydrogel. Polyphenols are derived from plants and, as well as their 
antibacterial effects, are known to possess antioxidative properties. This is beneficial in 
terms of bone tissue engineering, as oxidative stress has been indicated to impede both the 
differentiation of osteoblasts and the resorption of bone by osteoclasts, in-vitro (Bax et al., 
1992; Mody, 2001). The ability of phenolic compounds such as gallic acid (GA), isolated from 
terrestrial plants, and phloroglucinol (PG), found in seaweeds, to ameliorate oxidative stress 
has been documented on numerous occasions (Kim et al., 2012; Queguineur et al., 2012; 
Umadevi et al., 2012). Similarly, a study conducted by Lišková et al (2015) demonstrated that 
GA and PG both increased the antioxidant activity of chitosan hydrogels and decreased the 
colony forming ability of Escherichia coli. However, hydrogels containing GA (but not PG) 
were also found to be cytotoxic in cell culture, due to the release of toxic substances from 
the hydrogel into the culture medium.  
Therefore, in addition to the previously described CNT supplemented hydrogels, the present 
study incorporated PG into WPI hydrogels with the intention to create a biomaterial with 








13.1 Hydrogel Preparation:  
Stock solutions of 40% w/v whey protein isolate were prepared by dissolving WPI powder in 
deionised H2O. A sonicator was used to facilitate dissolution and minimise foaming. 
Subsequently, 500µl of stock solution was added to Eppendorf tubes alongside the required 
amount of Phloroglucinol (Sigma-Aldrich, Germany) to make 0 (control), 2.5, 5, 10, and 20% 
PG samples. Once in Eppendorf tubes, samples were vortexed until mixed homogenously. 
Samples were then autoclaved at 134°C for 20 minutes, to simultaneously sterilise and 
induce gelation of the samples.  
13.2 Scanning Electron Microscopy (SEM): 
Samples were prepared for SEM as previously described in chapter 3 section 8.4. 
13.3 Mechanical Testing:  
The effects of adding PG to WPI hydrogels on the hydrogels mechanical properties were 
evaluated in collaboration with Krzysztof Pietryga (AGH University of Science and 
Technology, Poland). Cylindrical samples of 2.5, 5, 10 and 20% PG, measuring 10mm in 
height and 8mm in diameter, were subject to compressive testing using a Zwick 1435 
Universal Testing Machine. Test parameters were set at a speed of 10mm per minute, and a 
test range of 0-95% strain.  
13.4 Cell Culture: 
To evaluate the interaction of the WPI-PG hydrogels with bone cells, a human osteosarcoma 
(MG-63) cell line was seeded on to the hydrogels as per method in chapter 3, section 8.7.   
13.4.1 Fluorescent Microscopy: 
At intervals of 1, 4 and 7 days, the adhesion, proliferation, and morphology of cells was 




13.4.2 Proliferation Assay (MTS) 
At intervals of 1, 4 and 7 days, MG-63 cell viability was evaluated via the MTS assay, as per 
method in chapter 3, section 8.7.2.  
 
14.0 Results 
Sample Abbreviation Description 
WPI Control 40% WPI - 0% PG hydrogel 
2.5% PG 40% WPI - 2.5% PG hydrogel 
5% PG 40% WPI - 5% PG hydrogel 
10% PG 40% WPI - 10% PG hydrogel 
20% PG 40% WPI - 20% PG hydrogel 
40% PG 40% WPI - 40% PG hydrogel 
 
 
14.1 Scanning Electron Microscopy (SEM) 
The microstructures of WPI-PG hydrogels with concentrations ranging from 0 to 20% PG 
were analysed via SEM. The WPI control (0% PG) sample (Figure 29A) presented a 
consistently smooth surface topography. As expected, the observed microstructure of 






























Figure 29: SEM images of WPI hydrogels containing PG at concentrations of 0% (A), 







14.2 Mechanical Testing 
It is important to note that, due to high friction, the WPI samples supplemented with 20% PG 
were stuck in the jaws of the Zwick testing machine, meaning values for strength, modulus 
and strain at break were overestimated. 
14.2.1 Compressive Strength 
No statistically significant difference in compressive strength was observed between the WPI 
control (0% PG) and the 2.5% PG sample group (mean values of 4.26 and 4.34MPa 
respectively). However, increasing the PG concentration to 5% resulted in the compressive 
strength decreasing by 1.35MPa to a mean of 2.91MPa. This reduction was deemed to be 
statistically significant compared to both the WPI control and the 2.5% PG sample group 
(P<0.05). Increasing the PG concentration to 10% demonstrated a mean compressive 
strength of 5.06MPa. However, values were inconsistent within this group and no statistical 
significance was proven. 
14.2.2 Young’s Modulus 
Except for the 20% PG sample group for which values were overestimated, no statistically 
significant difference in Young’s Modulus was observed between PG supplemented sample 
groups compared to the WPI control (Figure30B). The addition of 2.5% PG resulted in a 
negligible increase in Young’s Modulus, while 5% resulted in a negligible decrease. A 
statistically significant increase of 0.43MPa was observed when PG concentration was 
increased from 5% to 10%. However, all samples demonstrated a Young’s modulus between 
3 and 4MPa. 
14.2.3 Strain at Break 
Finally, the mean deformation observed for the WPI control (0% PG) sample group was 
7.09mm (70.92%). The addition of 2.5% PG to WPI hydrogels resulted in a slight increase in 




However, except for the overestimate in the 20% PG samples, the only statistically significant 
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Figure 30: Mechanical testing ol WPI hydrogels containing 0, 2.5, 5, 10 and 20% PG. A) 
Compressive strength, B) Young’s Modulus, C) Strain at break. * indicates statistical 
significance compared to the WPI control (P<0.05). # indicates significance between WPI-







14.3 Cell Culture:  
14.3.1 Fluorescent Microscopy: 
The adhesion, proliferation, and morphology of MG-63 cells cultured on WPI hydrogels 
supplemented with PG was evaluated, at intervals of 1, 4 and 7 days, by fluorescent 
microscopy (Figure 31). Prior to imaging, Hoechst stain was used to stain cell nuclei (blue), 
and Texas Red was utilised to stain the cytoplasmic regions (red). 
Imaging of the samples suggested that PG was leaching out of the hydrogels and having a 
negative impact on cell viability. This is evidenced in figure 31, as cells were visible on the 
hydrogels containing the lowest concentration of PG (2.5%); with the number of observable 
cells reducing with increasing PG concentration, to almost no cell coverage at 20% PG. These 
observations were consistent at all three time points (1, 4, and 7 days). However, despite the 
presence of cells on the 2.5 and 5% PG samples, none of the observed cells displayed a 
healthy morphology – cells were rounded rather than spread and well defined.  
Interestingly, what appeared to be crystalline structures were also observed on the surface 




































Figure 31:  Fluorescent microscopy of MG-63 osteoblast-like cells cultured on WPI 
hydrogels supplemented with PG at concentrations of 2.5%, 5%, 10% and 20% after 1 
and 7 days. Cells stained by Hoechst (nuclei, blue) and Texas Red (cell cytoplasm, red). 




14.3.2 Proliferation (MTS) Assay: 
Again, the MTS assay was utilised to allow the quantitative evaluation of cell metabolic 
activity – indirectly, proliferation, cell viability, and cytotoxicity of WPI-PG hydrogels.  
Prior to the subtraction of the absorbance value for the background (samples in the absence 
of cells), the MTS assay produced false positive results for WPI-PG hydrogels. The 
uncorrected absorbance values indicated high levels of cell proliferation, elevated compared 
to the polystyrene control, and increasing with increasing PG concentration. However, this 
was also observed for the unseeded samples, indicating that PG interferes with the MTS 
assay. 
When this was corrected for (background absorbance values subtracted), the values were 
close to 0, as displayed in figure 32. For each of the WPI-PG sample groups, the observed 
absorbance values were highest 24 hours after cell culture. No correlation between PG 
concentration and absorbance was observed - no statistically significant difference between 
2.5 or 20% PG samples was detected compared to the polystyrene control at the same time 
point, whereas 5 and 10% samples were significantly lower. Following the 4th and 7th day of 
cell culture, no obvious trend in absorbance was visible as all groups were close to 0, 

































































* * * * 
Figure 32: Proliferation of MG-63 osteoblast-like cells on 40% WPI hydrogels with PG 
concentrations 2.5, 5, 10 and 20% was assessed at 1, 4 and 7 days, via the MTS assay. 
As per method, hydrogels were placed in 100µl of MTS solution and incubated for 2 
hours. Absorbance was then measured via a spectrophotometer (at 490nm). # indicates 
statistical significance within sample groups (7) indicates the time period with the 
difference to. * indicates statistical significance compared to the polystyrene control at 





15.0 Discussion  
The purpose of current study was to evaluate the efficacy of WPI hydrogels supplemented 
with PG as materials with implications in bone tissue engineering applications. Alike gelatin 
hydrogels which can be simultaneously crosslinked and sterilised by electron irradiation, WPI 
hydrogels possess the advantage of simultaneous fabrication and sterilisation, as gelation is 
induced by heat. Furthermore, as WPI is a by-product when producing foods such as Greek 
yoghurt, it is a readily available low-cost material.  
Specific to bone tissue engineering, WPI has been shown to enhance human osteoblast-like 
Saos-2 (for which calcium deposition was also stimulated) and human neonatal dermal 
fibroblast (FIB) cell growth. Additionally, human adipose tissue derived stem cells (ASC) 
demonstrated WPI induced expression of markers characteristic of osteogenic cell 
differentiation (Douglas et al., 2018). All of which contributed to the decision to utilise WPI 
hydrogels in this study.  
Similarly, PG, a phenolic compound isolated from seaweed, was identified as a 
supplementary component of the experimental hydrogels due to their known antimicrobial 
and antioxidative properties. Specifically, the colony forming ability of Escherichia coli was 
reduced in chitosan hydrogels supplemented with PG (Lišková et al., 2015). 
15.1 Scanning Electron Microscopy (SEM) 
The effects of PG supplementation on the microstructure of WPI hydrogels was examined 
using SEM. As expected, the control WPI hydrogels (0% PG) displayed a homogenously 
smooth surface topography. With increasing PG concentration, hydrogels were observably 
rougher. This may be an advantage for their potential applications in bone tissue engineering 
as both stiffer and rougher surfaces are known to promote the differentiation of cells 
towards the osteoblastic phenotype. Although seemingly ‘free’ PG could be observed on the 




the WPI hydrogel. However, cross-sectional samples of these hydrogels must be imaged to 
confirm homogeneity of distribution and, therefore, the efficacy of vortexing the WPI/PG 
mixture before gelation. 
15.2 Mechanical Testing 
Minimal increases in both Young’s modulus and percentage strain at break were found to 
accompany PG supplementation at lower concentrations (2.5%). Since stiffer surfaces are 
known to promote the differentiation of cells towards the osteoblastic phenotype, PG 
imparted stiffness would improve the compatibility of these hydrogels with bone tissue. 
However, this effect was not observed in a dose-dependent manner. 
 The values for Young’s modulus, compressive strength and percentage strain at break 
remained relatively consistent throughout sample groups, even when the concentration of 
PG was increased to 10%. This suggests that the incorporation of PG into the WPI hydrogels 
has no significant impact on the overall structural function of WPI hydrogels. However, it is 
important to note that, due to high friction, the WPI hydrogels supplemented with 20% PG 
remained stuck in the jaws of the testing machine. As such, it is suggested that PG 
supplementation at higher concentration may alter the mechanical properties of WPI 
composites, resulting in ‘stickier’ hydrogels. 
15.3 Fluorescent Microscopy  
Although PG was identified to supplement hydrogels due to its antimicrobial activity, this 
must be achieved in the absence of cytotoxic effects, should these hydrogels be implicated in 
bone tissue regeneration.  
Thus, the ability of PG supplemented WPI hydrogels to support the adhesion and 
proliferation of MG-63 cells was evaluated. Cell viability appeared to reduce with increasing 
PG concentration. Interestingly, crystalline structures were also observed on the surface of 




culture, potentially due to the release of cytotoxic substances from the hydrogel into the 
culture medium. These observations contradict those by Lišková et al (2015) who found no 
cytotoxic effects of PG in cell culture. However, the same study documented the cytotoxic 
effects of gallic acid (Ga; an alternative phenolic compound). Therefore, future research is 
necessary to elucidate the mechanism of this apparent cytotoxicity. 
It should be noted that no control WPI (0% PG) sample was evaluated alongside the PG 
supplemented samples as they were subject to contamination prior to the cell culture 
procedure.  
15.4 Proliferation (MTS) Assay 
The MTS assay, which is a measure of cell metabolic activity, produced false positive results 
indicating high levels of cell proliferation even for unseeded WPI-PG hydrogels. This 
interference increased alongside increasing PG concentrations. Therefore, supporting the 
theory that substances are leached from the hydrogels into the cell culture medium.  
With the background corrected for, the observed absorbance values for each sample group 
was close to 0. Thus, providing further evidence for the cytotoxic effects of WPI-PG hydrogel 
leachables.  
15.5 Future 
Time constraints limited the number of analytical methods utilised to evaluate WPI-PG 
hydrogels. However, in the future degradation studies should be carried out and the 
substances leaching out of the hydrogels should be identified and evaluated. In the case of 
GA, previous research has reported that toxicity is concentration dependent and occurs via 
apoptosis as a result of elevated levels of reactive oxygen species (Lišková et al., 2015). 




As the antimicrobial properties of PG were the primary reason for incorporating it into the 
WPI hydrogels, antibacterial studies should also be carried out. For example, it should be 
elucidated whether PG supplemented hydrogels decrease the colony forming ability of E. coli 
as seen in chitosan hydrogels.   
16.0 Conclusion 
PG supplementation at lower concentrations demonstrated minimal impact on the 
mechanical properties of WPI hydrogels. Similarly, on the contrary to previous research PG 
appeared to be cytotoxic in cell culture, in a dose-dependent manner. Despite this, if the 
concentration dependent cytotoxicity of PG is clarified and future research demonstrated 
the ability of concentrations below this to provide antibacterial effects, WPI-PG hydrogels 
may still provide opportunities in the bone tissue engineering space. 
 
17.0 General Discussion  
The present study evaluated the extent to which physiochemical and biological properties 
desirable of materials for applications in bone tissue engineering were met by three 
hydrogels differing in composition:  
1. Electron irradiated Gelatin hydrogels supplemented with Alkaline Phosphatase (ALP) 
2. WPI hydrogels supplemented with Phloroglucinol (PG) 
3. WPI hydrogels supplemented with Carbon Nanotubes (CNTs) 
Previously, surgery took place in the absence of additives, such as implants, which are now 
available to facilitate surgical interventions. The demand for medical implants has been 
driven by advancements in the understanding of human anatomy and the identification of 




materials may be utilised as short term, long term, or permanent aids to treat, repair or 
replace biological tissue in numerous applications. 
As the average life-expectancy and chronological age of the human population rises, the 
incidence of bone related disorders and conditions has increased. Particularly in populations 
where obesity and insufficient physical activity coincides with aging. Even though bone is a 
dynamic vascularised tissue with the capability to heal naturally in response to damage, 
hundreds of millions of surgical procedures are performed, each year, to correct severe bone 
lesions (Maisani et al., 2017). Research into bone tissue engineering (BTE) has led to 
improvements in both surgical techniques and orthopaedic implants. However, skeletal 
conditions remain undertreated. Therefore, coinciding with the aging population, 
orthopaedic trauma and resultant orthopaedic surgery is becoming more frequent. Thus, 
highlighting the increasing need for cost efficient and effective treatments (Pilia et al., 2013). 
Conventional treatments of bone tissue defects include autografts, allografts, xenografts, 
and the implantation of exogenous biomaterials, such as metal or ceramics. All of which have 
considerable disadvantages. Although autologous bone grafts, where the recipient is also the 
donor, remain the ‘gold standard’ to augment bone tissue healing, their autologous nature 
means the supply of appropriate bone is limited. Similarly, there are multiple other concerns 
including donor site morbidity, surgical limitations, and elevated bone resorption during 
healing (Banwart et al., 1995; Sheikh et al., 2015).  
Allografts, the transfer of bone tissue sourced from a genetically different human donor, and 
xenografts, the transfer of bone tissue sourced from a different species, negate the concerns 
regarding donor site morbidity and allow greater quantities of bone tissue to be 
transplanted. However, due to the necessary sterilisation and purification processes that 
must precede transplantation, the osteoinductive properties that accompany autografts are 




elicit a significant immune response in the host tissue, ultimately leading to rejection unless 
immunosuppressive medication is received. Similarly, grafts of this nature are accompanied 
by the risk of bacterial, viral, and prion transmission (Mankin et al., 2005). Finally, 
allografts/xenografts rarely integrate fully with host tissue. Most transplants result in only 
the periphery of the graft substituting successfully, leading to a subsequent graft fracture in 
as many as 60% of cases after 10 years (Wheeler and Enneking, 2005). 
The use of large prostheses, such as metals and metal alloys, is an additional method to 
remedy bone tissue defects. However, prostheses of this kind are usually a temporary 
solution, with 30% of recipients requiring a revision 7 years after the original procedure 
(Mittermayer et al., 2001). This is because metal/metal alloy implants lack a biological 
interface. As they do not interact, either chemically or biologically, with the surrounding 
tissue, there is minimal osteointegration or interfacial bonding. Therefore, over time, chronic 
wear or loosening renders the implant ineffective (Schroeder and Mosheiff, 2011). 
Additionally, ‘stress shielding’ which occurs due to the mismatch in mechanical properties 
between metallic implants and natural bone tissue results in unwanted bone resorption and 
implant loosening (Alexander and Theodos, 1993). Similarly, implants of this nature are 
known to damage host tissue due to their weight and robustness, release toxic ions and 
particles via corrosion and cause allergic reactions and inflammatory cascades (Mediaswanti 
et al., 2013 and Poinern et al., 2013).  
Despite the varying advantages which accompany each of these conventional techniques, 
their overall effectiveness remains inadequate. In the USA alone, projections for the demand 
of hip and knee implants were estimated to increase by 174% and 673%, respectively, 
between 2005 and 2030 (Kurtz et al., 2007). Similarly, in Australia, primary and revision hip 
surgery numbers were elevated by approximately 17% in 2008 compared to the previous 




biomechanically and biocompatible materials for use in orthopaedic applications – a space 
which the materials evaluated in this study show promise.  
Like allografts and xenografts, the materials examined in the present study negate the 
concerns with donor site morbidity and limited material supply associated with autografts. 
However, in contrast, the hydrogels utilised in this study avoid the risk of bacterial, viral, and 
prion transmission in the absence of a pre-implantation purification processes known to 
diminish the osteoinductive properties of the implant (Schroeder and Mosheiff, 2011). 
Specifically, simultaneous formation and sterilisation is achieved via electron irradiation 
(Gelatin hydrogels) and by autoclaving (WPI hydrogels). 
Similarly, as preliminary in-vitro studies demonstrated that CNT supplemented WPI 
hydrogels and electron beam-crosslinked hydrogels, both mineralised and unmineralized, 
displayed satisfactory cytocompatibility towards human osteoblast-like MG-63 cells, these 
materials show promise as potential scaffolds for autologous cells. Therefore, as well as the 
absence of an elicited immune response that accompanies allografts, potential scaffolds 
constructed from these materials may possess the ability to induce the osteogenic 
differentiation of local stem cells that is observed following autografts (Goldberg, 2000; Shen 
et al., 2005; Urist, 1980). PG supplemented hydrogels, however, demonstrated cytotoxicity 
in a dose-dependent manner. As such, WPI-PG hydrogels (currently) do not show promise in 
this space. 
Compared to metal/metal alloy implants, the primary advantages suggested of electron 
irradiated gelatin hydrogels is, in fact, mineralisation. Whereas metal/metal alloy implants 
do not possess a biological interface capable of effective osteointegration (Schroeder and 
Mosheiff, 2011), mineralisation is known to enhance the biological performance of bone-
substituting materials by a phenomenon of bioactivity (LeGeros, 1991). Additionally, CaP 




growth factors, which are necessary for the natural healing process of bone tissue (Ruhe et 
al., 2005). Therefore, the successful CaP mineralisation of gelatin hydrogels is promising. 
However, as with the study by Osathanon et al., (2009) that demonstrated the ability of a 
fibrin gel to enhance bone tissue formation in a mouse calvarial defect following ALP 
mediated mineralisation, this material must be evaluated in-vivo. 
WPI based hydrogels were not subject to this mineralisation process. However, a study 
conducted by Douglas et al (2018) demonstrated that, in addition to stimulating calcium 
deposition by Saos-2 cells and elevating the expression of type I collagen by FIB, WPI induced 
the expression of markers characteristic of osteogenic cell differentiation by human adipose 
tissue derived stem cells (ASC). Furthermore, increased ALP activity was observed. Similarly, 
Zhao et al (2005) noted that CNTs promoted the formation of mineralised bone while Usui et 
al (2008) demonstrated that, in a mouse model, MWCNTs were biocompatible, permitted 
bone repair, and became integrated with bone tissue.  
ALP mediated mineralisation was also demonstrated to elevate the compressive modulus of 
gelatin hydrogels. The effect of supplementing WPI hydrogels with CNTs or PGs on their 
compressive strength was inferior to that of gelatin mineralisation, however, increases in 
Young’s modulus were observed, in a dose-dependent manner, following CNT 
reinforcement. Typically, hydrogels possess weak mechanical properties, meaning that, 
without reinforcement, their implications are somewhat restricted to soft tissue engineering. 
However, as noted by Douglas et al (2013), the mechanical reinforcement brought about by 
mineralisation enables them to be considered for bone tissue regeneration (Douglas et al., 
2013). The elevated mechanical properties may also improve the compatibility of the 
hydrogels with bone tissue, as both stiffer and rougher surfaces are known to promote the 




mechanical properties observed, particularly in the mineralised gelatin hydrogels, implicates 
them in bone tissue engineering applications.  
Implant-related microbial infections remain one of the primary causes of wound healing 
complications and failure of orthopaedic implants (Romano et al., 2015; Salomé Veiga and 
Schneider, 2013). Specifically, pathogenicity at the tissue-implant interface can compromise 
wound healing and lead to the failure of orthopaedic implants (Salomé Veiga and Schneider, 
2013). Importantly, pathogens that possess multi-resistance are also frequently isolated 
from complication sites (Aggarwal et al., 2014).  
CNTs are known to possess antimicrobial activity against a broad spectrum of 
microorganisms. The first evidence of this was documented by Kang et al (2007) who 
observed antimicrobial activity of both SWNTs and MWNTs against Escherichia coli. Since 
this time, numerous studies have implicated CNTs in applications for the inactivation of 
pathogens (Liu et al., 2018).  Similarly, a study conducted by Lišková et al (2015) 
demonstrated that PG decreased the colony forming ability of Escherichia coli. Thus, the 
present study aimed to evaluate the antibacterial properties of WPI hydrogels supplemented 
with CNT and PG.  
Antibacterial testing was only performed on WPI-CNT hydrogels. However, CNT inclusion 
successfully provided WPI hydrogels with antibacterial effects against Staphylococcus aureus.  
Ultimately, the present study concludes that hydrogels comprised of both gelatin and WPI 
show promise in this field. Specifically, the composites examined in this study, except for PG 
supplemented WPI hydrogels, show potential as candidates for use in bone tissue 
engineering applications. However, further research must be conducted with lower CNT 
concentrations to identify whether an increase in compressive strength can be supplied, 
without detracting from the observed antibacterial activity. Similarly, further research 




tissue engineering. WPI hydrogels could also be supplemented with alternative additives to 
optimise their properties for application in this space. Furthermore, prior to their use in bone 
tissue engineering applications, the long-term activity of hydrogel composites, specifically in-
vivo, should be elucidated. Cytotoxicity, biocompatibility, biodegradability, and osteogenicity 
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